Â© 2000-2024 QIAGEN. All rights reserved.

Ingenuity Canonical Pathways	 -log(p-value)	Ratio	z-score	Molecules	
Eukaryotic Translation Initiation	7.11E01	6.39E-01	-8.832	EIF2B4,EIF2S2,EIF3E,EIF3F,EIF3G,EIF3H,EIF3I,EIF3J,EIF3K,EIF3M,EIF4A1,EIF4E,EIF4EBP1,EIF4H,FAU,RPL10,RPL10A,RPL11,RPL13,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA	
SRP-dependent cotranslational protein targeting to membrane	6.93E01	6.52E-01	-8.660	DDOST,FAU,RPL10,RPL10A,RPL11,RPL13,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,SEC11A,SEC11C,SEC61B,SEC61G,SPCS2,SRP14,SRP19,SRP9,SSR2,SSR4	
Eukaryotic Translation Elongation	6.55E01	7.05E-01	-8.185	EEF1A1,EEF1B2,EEF1D,FAU,RPL10,RPL10A,RPL11,RPL13,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA	
Response of EIF2AK4 (GCN2) to amino acid deficiency	6.5E01	6.7E-01	-8.307	ATF3,ATF4,CEBPG,DDIT3,EIF2S2,FAU,RPL10,RPL10A,RPL11,RPL13,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA	
Eukaryotic Translation Termination	6.27E01	6.91E-01	-8.062	FAU,RPL10,RPL10A,RPL11,RPL13,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,TRMT112	
EIF2 Signaling	6.05E01	4.04E-01	-5.940	ACTB,ATF3,ATF4,DDIT3,EIF2B4,EIF2S2,EIF3E,EIF3F,EIF3G,EIF3H,EIF3I,EIF3J,EIF3K,EIF3M,EIF4A1,EIF4A3,EIF4E,FAU,HRAS,HSPA5,MAPK3,PPP1CA,Ppp1cc,PPP1R15A,RASD1,RPL10,RPL10A,RPL11,RPL13,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,Rpl22l1,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,Rpl34 (includes others),RPL35,RPL35A,Rpl36,Rpl36a,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,RRAS	
Selenoamino acid metabolism	5.56E01	5.98E-01	-8.000	FAU,RPL10,RPL10A,RPL11,RPL13,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA	
Nonsense-Mediated Decay (NMD)	5.5E01	5.64E-01	-8.124	EIF4A3,FAU,RBM8A,RPL10,RPL10A,RPL11,RPL13,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA	
Major pathway of rRNA processing in the nucleolus and cytosol	4.75E01	3.98E-01	-8.602	BUD23,C1D,CSNK1E,DDX21,EBNA1BP2,EMG1,FAU,FCF1,RPL10,RPL10A,RPL11,RPL13,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,RRP7A,SNU13,UTP11	
Oxidative Phosphorylation	3.16E01	4.2E-01	-6.782	COX17,COX4I1,COX5A,COX6B1,Cox6c,COX7A2,COX7A2L,COX8A,CYB5A,CYCS,NDUFA1,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS7,NDUFV1,NDUFV2,NDUFV3,SDHB,SDHD,SURF1,UQCR10,UQCR11,UQCRB,UQCRC1,UQCRFS1,UQCRHL,UQCRQ	
BAG2 Signaling Pathway	2.69E01	4.47E-01	-1.508	ANXA2,CDKN1A,HSP90AA1,HSPA14,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,MAPK3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,SEM1,STUB1	
Sirtuin Signaling Pathway	2.65E01	2.3E-01	2.236	ATG101,BAX,GABARAP,GABARAPL2,GADD45B,GADD45G,H3-3A/H3-3B,JUN,LDHA,MAP1LC3A,MAP1LC3B,MAPK3,NDUFA1,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS7,NDUFV1,NDUFV2,NDUFV3,NFE2L2,NR1H2,PGAM1,POLR1D,POLR2F,PPID,SDHB,SDHD,SLC25A4,SLC25A5,TIMM13,TIMM17A,TIMM23,TIMM50,TIMM8B,TOMM20,TOMM22,TOMM40,TOMM6,TOMM7,TSPO,TUBA1A,TUBA1B,TUBA1C,UQCRFS1,VDAC1,VDAC2,VDAC3	
Electron transport, ATP synthesis, and heat production by uncoupling proteins	2.63E01	3.52E-01	-6.708	COX20,COX4I1,COX5A,COX6B1,COX7A2L,COX8A,CYCS,NDUFA1,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC2,NDUFS2,NDUFS3,NDUFS7,NDUFV1,NDUFV2,NDUFV3,SDHB,SDHD,SURF1,UQCR10,UQCR11,UQCRB,UQCRC1,UQCRFS1,UQCRHL,UQCRQ	
NIK-->noncanonical NF-kB signaling	2.58E01	5.33E-01	-5.657	NEDD8,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC,UBE2M	
Mitochondrial Dysfunction	2.57E01	2.09E-01	6.053	ATF4,BAD,BAX,BBC3,Calm1 (includes others),COX17,COX4I1,COX5A,COX6B1,Cox6c,COX7A2,COX7A2L,COX8A,CREB3,CYB5A,CYCS,FIS1,GPX1,GPX4,GSTM2,MGST3,NDUFA1,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS7,NDUFV1,NDUFV2,NDUFV3,NFE2L2,PARK7,PDHB,PRDX6,PRKAB1,PRKAR1A,PSENEN,SDHB,SDHD,SURF1,TOMM20,TOMM22,TOMM40,TOMM7,UQCR10,UQCR11,UQCRB,UQCRC1,UQCRFS1,UQCRHL,UQCRQ,VDAC1,VDAC2,VDAC3	
Regulation of Apoptosis	2.53E01	5.66E-01	-5.477	PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC	
Huntington's Disease Signaling	2.48E01	2.25E-01	-1.941	AP2A2,ATF4,BAX,CLTA,CLTB,CREB3,CYCS,GNA11,GNB2,GNG11,GNG5,HRAS,HSPA14,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,JUN,MAPK3,NAPA,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SDHB,SDHD,SEM1,SGK1,Ubb,UBC,UBE2S,VAMP3,VTI1B	
Metabolism of polyamines	2.48E01	5.25E-01	-5.568	AMD1,OAZ1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,SAT1,SEM1	
Cellular response to hypoxia	2.44E01	4.53E-01	-5.831	EGLN2,ELOC,HIGD1A,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC,UBE2D3	
FAT10 Signaling Pathway	2.4E01	5.26E-01	NaN	MAP1LC3B,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,SEM1,SQSTM1	
TNFR2 non-canonical NF-kB pathway	2.36E01	4.71E-01	-5.657	PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,TNFRSF12A,TNFSF12,UBC	
mTOR Signaling	2.27E01	2.48E-01	-3.051	Cdc42,EIF3E,EIF3F,EIF3G,EIF3H,EIF3I,EIF3J,EIF3K,EIF3M,EIF4A1,EIF4A3,EIF4E,EIF4EBP1,FAU,FKBP1A,HRAS,MAPK3,PPP2R2D,PRKAB1,RASD1,RHEB,RHOA,RHOB,RHOC,RHOG,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,RRAS	
Signaling by NOTCH4	2.26E01	4.1E-01	-5.831	HES1,HEY1,PSENEN,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,SNW1,UBC	
KEAP1-NFE2L2 pathway	2.21E01	3.85E-01	-5.916	CDKN1A,CSNK2B,MAP1LC3B,NFE2L2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,SQSTM1,UBC	
Protein Ubiquitination Pathway	2.19E01	2.16E-01	NaN	ANAPC11,BAG1,DNAJA1,DNAJB11,DNAJB2,ELOC,HLA-A,HLA-E,HLA-G,HSP90AA1,HSP90AB1,HSP90B1,HSPA14,HSPA1A/HSPA1B,HSPA5,HSPA8,HSPB1,HSPD1,HSPE1,HSPH1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,STUB1,TAP2,Ubb,UBC,UBE2A,UBE2B,UBE2D3,UBE2G2,UBE2I,UBE2M,UBE2S	
Hedgehog ligand biogenesis	2.19E01	4.62E-01	-5.477	PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC	
Regulation of eIF4 and p70S6K Signaling	2.16E01	2.61E-01	-2.000	EIF2B4,EIF2S2,EIF3E,EIF3F,EIF3G,EIF3H,EIF3I,EIF3J,EIF3K,EIF3M,EIF4A1,EIF4A3,EIF4E,EIF4EBP1,FAU,HRAS,MAPK3,PAIP2,PPP2R2D,RASD1,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,RRAS	
Regulation of mitotic cell cycle	2.16E01	3.86E-01	-5.831	ANAPC11,BUB3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,PTTG1,RPS27A,SEM1,UBC,UBE2S	
Hedgehog 'off' state	2.15E01	3.36E-01	-5.477	GNAS,PRKAR1A,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B,UBC	
Mitochondrial translation	2.12E01	3.65E-01	-5.916	AURKAIP1,CHCHD1,GADD45GIP1,MRPL12,MRPL15,MRPL17,MRPL18,MRPL22,MRPL24,MRPL30,MRPL33,MRPL35,MRPL38,MRPL4,MRPL43,MRPL44,MRPL53,MRPL54,MRPL58,MRPL9,MRPS12,MRPS14,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS21,MRPS23,MRPS24,MRPS26,MRPS30,MRPS6,MRPS7,TSFM	
Regulation of RUNX2 expression and activity	2.12E01	4.25E-01	-5.568	PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,STUB1,UBC	
MAPK6/MAPK4 signaling	2.09E01	3.7E-01	-2.000	CDC42EP2,CDC42EP3,HSPB1,JUN,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC	
Mitotic Metaphase and Anaphase	1.99E01	2.21E-01	-7.211	ANAPC11,BUB3,CHMP2A,CHMP6,DYNLL1,EMD,IST1,LMNA,NDEL1,NUDC,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,PTTG1,RAN,RPS27A,SEC13,SEM1,SUMO1,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B,UBC,UBE2I,UBE2S	
PTEN Regulation	1.94E01	2.73E-01	-5.284	CSNK2B,JUN,LAMTOR2,LAMTOR3,MAPK3,MBD3,PHC2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RHEB,RPS27A,RRAGA,SEM1,STUB1,UBC,VAPA	
Mitotic G2-G2/M phases	1.92E01	2.36E-01	-6.856	CDKN1A,CETN2,CSNK1E,DCTN2,DCTN3,DYNLL1,HSP90AA1,HSP90AB1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,SSNA1,TUBA1A,TUBA1B,TUBA1C,TUBB,TUBB2A,TUBB2B,TUBB4B,UBC,YWHAE	
Estrogen Receptor Signaling	1.91E01	1.69E-01	-4.110	ATF4,BAD,CAV1,CDK8,CDKN1A,CFL1,CFL2,CREB3,DDX5,EIF2B4,EIF4E,EIF4EBP1,FOS,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,GPER1,HES1,HRAS,HSP90AA1,HSP90AB1,HSP90B1,JUN,MAPK3,MED10,MED21,MMP15,MYL12A,MYL12B,MYL6,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS7,NDUFV1,NDUFV2,NDUFV3,PDIA3,PRKAB1,PRKAR1A,RASD1,RHOA,RRAS,SDHB,SDHD,SRA1,UQCRFS1	
Transcriptional regulation by RUNX3	1.91E01	3.44E-01	-5.657	CDKN1A,HES1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,SNW1,UBC	
Degradation of beta-catenin by the destruction complex	1.77E01	3.37E-01	-5.568	PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,TLE5,UBC	
Hedgehog 'on' state	1.77E01	3.49E-01	-5.477	PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC	
Microautophagy Signaling Pathway	1.74E01	2.5E-01	-6.245	CHMP2A,CHMP5,CHMP6,HSPA8,MAP1LC3A,MAP1LC3B,PRKAB1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,SEC13,SQSTM1,TOMM20,VAMP8,VPS28,VPS37B	
Signaling by ROBO receptors	1.72E01	2.93E-01	-5.831	ELOC,PFN1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RHOA,RPS27A,SEM1,UBC,VASP	
DNA Replication Pre-Initiation	1.69E01	3.08E-01	-5.657	ANAPC11,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC,UBE2S	
Neddylation	1.67E01	1.99E-01	-7.000	BTBD6,CDKN1A,COMMD3,COMMD4,COMMD8,COPS5,COPS8,DCUN1D5,ELOC,FBXO22,NAE1,NEDD8,NFE2L2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RNF7,RPS27A,SEM1,SOCS2,SPSB3,SQSTM1,UBC,UBE2D3,UBE2M	
Processing of Capped Intron-Containing Pre-mRNA	1.66E01	1.85E-01	-7.280	BCAS2,CCDC12,CWC15,DDX39B,DDX5,EIF4A3,EIF4E,FAM32A,HNRNPA2B1,HNRNPF,HNRNPK,HNRNPM,HSPA8,LSM2,LSM3,LSM5,PCBP1,PHF5A,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,PPIE,RBM22,RBM42,RBM7,RBM8A,SAP18,SARNP,SEC13,SF3B4,SF3B6,SMNDC1,SNRNP27,SNRPB,SNRPD1,SNRPD3,SNRPF,SNU13,SNW1,SRSF2,SRSF3,SRSF7,SRSF9,SYF2,TXNL4A,UBL5,YBX1,ZCRB1,ZMAT5	
Granzyme A Signaling	1.65E01	3.65E-01	5.196	NDUFA1,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS7,NDUFV1,NDUFV2,NDUFV3	
S Phase	1.65E01	3.1E-01	-5.568	CDKN1A,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC	
ABC-family proteins mediated transport	1.64E01	3.07E-01	-5.568	EIF2S2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC	
C-type lectin receptors (CLRs)	1.56E01	2.48E-01	-5.831	BCL10,HRAS,ICAM2,NEDD8,NFKBIA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC,UBE2M	
TCR signaling	1.51E01	2.62E-01	-5.745	BCL10,NFKBIA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC,VASP	
Synthesis of DNA	1.5E01	2.69E-01	-5.657	ANAPC11,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC,UBE2S	
HSP90 chaperone cycle for steroid hormone receptors in the presence of ligand	1.46E01	4E-01	-4.690	ACTR10,CAPZA2,DCTN2,DCTN3,DCTN4,DCTN6,DNAJA1,DNAJA2,DYNLL1,FKBP4,HSP90AA1,HSP90AB1,HSPA1A/HSPA1B,HSPA8,PTGES3,STIP1,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B	
Transcriptional regulation by RUNX1	1.41E01	2.3E-01	-5.916	CLDN5,CSNK2B,CTSV,LMO2,PHC2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC	
Interleukin-1 family signaling	1.4E01	2.48E-01	-5.657	NFKBIA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,SQSTM1,UBC	
Inhibition of ARE-Mediated mRNA Degradation Pathway	1.39E01	2.21E-01	-2.121	MAPK3,PPP2R2D,PRKAR1A,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,SEM1,TNFSF12,YWHAE,YWHAH,YWHAQ,ZFP36	
Class I MHC mediated antigen processing and presentation	1.38E01	1.52E-01	-7.550	ANAPC11,BCAP31,BTBD6,CTSV,CYBA,ELOC,FBXO22,HLA-A,HLA-E,HLA-G,HSPA5,PDIA3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RCHY1,RNF126,RNF7,RPS27A,SAR1B,SEC13,SEM1,STUB1,TAP2,UBC,UBE2A,UBE2B,UBE2D3,UBE2G2,UBE2M,UBE2S,VAMP3,VAMP8	
Deubiquitination	1.35E01	1.75E-01	-6.782	ACTB,ADRB2,ADRM1,FKBP8,INO80B,MAT2B,NEDD8,NFKBIA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RAD23A,RHOA,RPS27A,RUVBL1,SEM1,SNX3,TOMM20,UBC,VDAC1,VDAC2,VDAC3	
Neutrophil degranulation	1.34E01	1.37E-01	-8.062	ACAA1,ACTR10,ALDOA,ANXA2,AP2A2,ARPC5,ATP6V0C,BRI3,CCT2,CCT8,CEACAM1,CNN2,COMMD3,CSNK2B,CST3,CTSH,CYBA,DDOST,DYNLL1,EEF1A1,FTH1,FTL,HSP90AA1,HSP90AB1,HSPA1A/HSPA1B,HSPA8,ILF2,IST1,JUP,LAMP1,LAMTOR2,LAMTOR3,NDUFC2,NME2,OSTF1,PFKL,PGAM1,PGRMC1,PKM,PLAUR,PNP,PPIA,PPIE,PRDX6,PSMA2,PSMA5,PSMB1,PSMC2,PSMC3,PSMD11,PSMD12,PSMD13,PSMD6,RAB18,RHOA,RHOG,RNASET2,SDCBP,SERPINB6,SRP14,TTR,TUBB,TUBB4B,VAMP8,VAPA	
Signaling by the B Cell Receptor (BCR)	1.33E01	2.12E-01	-6.000	BCL10,FKBP1A,HRAS,NFKBIA,ORAI1,PPIA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC	
Glucocorticoid Receptor Signaling	1.31E01	1.25E-01	NaN	ACTB,ADRB2,BAG1,CAV1,CDKN1A,DUSP1,FKBP4,FOS,GTF2B,H2-T22,H3-3A/H3-3B,HLA-A,HLA-E,HLA-G,HRAS,HSP90AA1,HSP90AB1,HSP90B1,HSPA14,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,IL10RB,JUN,MAPK3,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS7,NDUFV1,NDUFV2,NDUFV3,NFKBIA,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,PRKAB1,PTGES3,RASD1,RRAS,SDHB,SDHD,SGK1,SRA1,SUMO1,TSC22D3,UBE2I,UQCRFS1,YWHAH	
Mitotic G1 phase and G1/S transition	1.29E01	2.37E-01	-5.385	CDKN1A,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC	
Coronavirus Pathogenesis Pathway	1.29E01	1.91E-01	4.003	ATF4,BAX,DDIT3,EEF1A1,EIF4E,FAU,FOS,IRF7,JUN,MAPK3,NFKBIA,NPM1,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA	
TCF dependent signaling in response to WNT	1.18E01	1.86E-01	-6.083	CAV1,CSNK1E,CSNK2B,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,RUVBL1,SEM1,SOX17,SOX7,TLE5,UBC	
Phagosome Maturation	1.16E01	2.01E-01	NaN	ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,CTSH,CTSV,DCTN4,Dync1i2,DYNLL1,DYNLRB1,DYNLT3,HLA-A,HLA-E,HLA-G,LAMP1,NAPA,PRDX1,PRDX2,PRDX6,RAB5A,TUBA1A,TUBA1B,TUBA1C,TUBB,TUBB2A,TUBB2B,TUBB4B,VAMP3,VPS28,VPS37B,VTI1B	
Protein folding	1.13E01	2.55E-01	-5.000	ACTB,CCT2,CCT3,CCT4,CCT5,CCT7,CCT8,CSNK2B,GNA11,GNB2,GNG11,GNG5,GNGT2,PFDN1,PFDN5,TBCA,TBCB,TBCC,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B,VBP1	
RAF/MAP kinase cascade	1.11E01	1.6E-01	-6.403	ACTB,ACTG1,DUSP1,DUSP8,HBEGF,HRAS,LAMTOR2,LAMTOR3,MAPK3,PDGFA,PDGFB,PEBP1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC	
Mitochondrial protein import	1.1E01	3.12E-01	-4.472	CHCHD2,COX17,GRPEL1,HSPD1,IDH3G,NDUFB8,PMPCB,SLC25A4,TIMM10B,TIMM13,TIMM17A,TIMM23,TIMM50,TIMM8B,TOMM20,TOMM22,TOMM40,TOMM6,TOMM7,VDAC1	
Fc epsilon receptor (FCERI) signaling	1.07E01	1.75E-01	-5.831	BCL10,FOS,HRAS,JUN,MAPK3,NFKBIA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEM1,UBC	
Cell Cycle Checkpoints	1E01	1.51E-01	-6.403	ANAPC11,BUB3,CDKN1A,DYNLL1,NDEL1,NUDC,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,RPS27A,SEC13,SEM1,UBC,UBE2S,YWHAE,YWHAH,YWHAQ	
Cachexia Signaling Pathway	9.87E00	1.33E-01	-6.429	ADRB2,EIF2B4,EIF2S2,GNAS,HSP90AA1,HSP90AB1,HSP90B1,HSPA14,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,IFNGR1,MALAT1,MAP1LC3B,MAPK3,PRKAB1,PRKAR1A,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD10,PSMD11,PSMD12,PSMD13,PSMD6,PSMD8,PSME1,S1PR1,TNFRSF12A,TNFSF12,XBP1	
Neutrophil Extracellular Trap Signaling Pathway	9.57E00	1.28E-01	-7.141	MAPK3,MCL1,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS7,NDUFV1,NDUFV2,NDUFV3,ORAI1,PDIA3,PPID,PRDX6,SDHB,SDHD,SLC25A4,SLC25A5,TIMM13,TIMM17A,TIMM23,TIMM50,TIMM8B,TOMM20,TOMM22,TOMM40,TOMM6,TOMM7,TSPO,UQCRFS1,VDAC1,VDAC2,VDAC3	
EPH-Ephrin signaling	9.28E00	2.34E-01	-4.690	ACTB,ACTG1,AP2A2,Ap2b1,AP2M1,AP2S1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,CFL1,CLTA,CLTB,HRAS,MYL12A,MYL12B,MYL6,PSENEN,RHOA,SDCBP	
Remodeling of Epithelial Adherens Junctions	8.63E00	2.65E-01	-3.000	ACTB,ACTG1,ARF6,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,RAB5A,TUBA1A,TUBA1B,TUBA1C,TUBB,TUBB2A,TUBB2B,TUBB4B	
COPI-mediated anterograde transport	8.56E00	2.16E-01	-4.690	ACTR10,ARF1,ARF4,ARF5,CAPZA2,COPE,DCTN2,DCTN3,DCTN4,DCTN6,DYNLL1,KDELR1,NAPA,TMED10,TMED2,TMED9,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B	
Clathrin-mediated endocytosis	8.54E00	1.92E-01	-5.000	ACTB,ACTG1,ADRB2,AP2A2,Ap2b1,AP2M1,AP2S1,ARF6,ARPC1A,ARPC2,ARPC3,ARPC4,ARPC5,CLTA,CLTB,HBEGF,HSPA8,NECAP2,RAB5A,RPS27A,SH3GL1,TRIP10,UBC,VAMP3,VAMP8	
NRF2-mediated Oxidative Stress Response	8.41E00	1.48E-01	-4.379	ACTB,ACTG1,AKR1A1,ATF4,CCT7,CLPP,DNAJA1,DNAJA2,DNAJB11,DNAJB2,ERP29,FOS,FTH1,FTL,GCLM,GSTM2,HERPUD1,HRAS,HSP90AA1,HSP90AB1,HSP90B1,JUN,JUNB,JUND,MAFF,MAPK3,MGST3,NFE2L2,PPIB,PRDX1,RASD1,RRAS,SQSTM1,STIP1,TXN	
TP53 Regulates Metabolic Genes	8.26E00	2.27E-01	-4.472	COX20,COX4I1,COX5A,COX6B1,COX7A2L,COX8A,CYCS,LAMTOR2,LAMTOR3,NDUFA4,PRDX1,PRDX2,PRKAB1,RHEB,RRAGA,SURF1,TXN,YWHAE,YWHAH,YWHAQ	
Cellular response to heat stress	8.23E00	2.16E-01	-4.359	BAG1,BAG5,EEF1A1,FKBP4,HIKESHI,HSBP1,HSP90AA1,HSP90AB1,HSPA14,HSPA1A/HSPA1B,HSPA5,HSPA8,HSPB1,HSPH1,MAPK3,MRPL18,PTGES3,SEC13,SERPINH1,ST13,YWHAE	
Mitophagy	8.23E00	4E-01	-3.464	CSNK2B,MAP1LC3A,MAP1LC3B,RPS27A,SQSTM1,TOMM20,TOMM22,TOMM40,TOMM6,TOMM7,UBC,VDAC1	
MHC class II antigen presentation	8.14E00	1.9E-01	-4.899	ACTR10,AP1S1,AP1S2,AP2A2,AP2M1,AP2S1,ARF1,CAPZA2,CLTA,CTSH,CTSV,DCTN2,DCTN3,DCTN4,DCTN6,DYNLL1,SAR1B,SEC13,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B	
Hypoxia Signaling in the Cardiovascular System	7.8E00	2.37E-01	-2.449	ATF4,COPS5,CREB3,EDN1,HSP90AA1,HSP90AB1,HSP90B1,JUN,LDHA,NFKBIA,SUMO1,UBE2A,UBE2B,UBE2D3,UBE2G2,UBE2I,UBE2M,UBE2S	
Nucleotide Excision Repair	7.49E00	2.06E-01	-4.472	CETN2,COPS5,COPS8,HMGN1,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,PPIE,RAD23A,RPS27A,SUMO1,SUMO2,SUMO3,TCEA1,UBC,UBE2I	
Clathrin-mediated Endocytosis Signaling	7.07E00	1.44E-01	NaN	ACTB,ACTG1,AP1S1,AP1S2,AP2A2,Ap2b1,AP2M1,AP2S1,APOE,ARF6,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,CLTA,CLTB,CSNK2B,HSPA8,PDGFA,PDGFB,RAB11A,RAB5A,RPS27A,SH3GL1,SH3GLB1,Ubb,UBC	
Signaling by Rho Family GTPases	7.07E00	1.31E-01	-4.811	ACTB,ACTG1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,Cdc42,CDC42EP1,CDC42EP2,CDC42EP3,CDH5,CFL1,CFL2,FOS,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,JUN,MAPK3,MYL12A,MYL12B,MYL6,RDX,RHOA,RHOB,RHOC,RHOG,STMN1,VIM	
Integrin Signaling	6.88E00	1.42E-01	-3.024	ACTB,ACTG1,ARF1,Arf2,ARF4,ARF5,ARF6,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,CAV1,Cdc42,HRAS,ILK,MAPK3,MYL12A,MYL12B,PDGFB,PFN1,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,VASP	
Intra-Golgi and retrograde Golgi-to-ER traffic	6.76E00	1.43E-01	-5.385	ACTR10,ARF1,ARF4,ARF5,ARL1,CAPZA2,COPE,CYTH2,DCTN2,DCTN3,DCTN4,DCTN6,DYNLL1,KDELR1,NAA38,NAPA,PLIN3,RAB18,RAB9A,TMED10,TMED2,TMED9,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B,VAMP3	
Unfolded protein response	6.6E00	2E-01	-3.606	ATF4,CEBPG,DDIT3,DNAJA1,DNAJA2,DNAJB11,DNAJB2,HSP90B1,HSPA14,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,HSPH1,NFE2L2,PDIA6,PPP1R15A,XBP1	
Ferroptosis Signaling Pathway	6.5E00	1.68E-01	-1.706	ARF1,Arf2,ARF4,ARF5,ARF6,ATF4,CDKN1A,FTH1,FTL,G3BP1,GPX4,HRAS,HSPB1,MAPK3,NFE2L2,PEBP1,PRKAB1,RASD1,RRAS,SAT1,SQSTM1,VDAC2	
Gap junction trafficking and regulation	6.48E00	3.24E-01	-3.317	ACTB,ACTG1,AP2M1,CLTA,CLTB,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B	
Chaperone Mediated Autophagy	6.41E00	4.09E-01	-3.000	EEF1A1,HSP90AA1,HSP90AB1,HSPA8,PARK7,PLIN3,RPS27A,UBC,VIM	
Aggrephagy	6.23E00	2.79E-01	-3.464	DYNLL1,HSP90AA1,PARK7,RPS27A,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B,UBC,VIM	
ROBO SLIT Signaling Pathway	6.12E00	1.65E-01	2.400	ARF1,Arf2,ARF4,ARF5,ARF6,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,CDKN1A,FOS,HES1,JUN,MYL12A,MYL12B,NDFIP1,PRKAR1A,RHOA	
RNA Polymerase II Transcription	6.1E00	1.54E-01	-4.796	CDK9,DDX39B,EIF4A3,ELOC,GTF2B,LSM10,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,RBM8A,SARNP,SNRPB,SNRPD3,SNRPF,SRSF2,SRSF3,SRSF7,SRSF9,TCEA1	
Signaling by TGF-beta Receptor Complex	5.99E00	2.45E-01	-3.606	F11R,FKBP1A,LTBP4,NEDD8,PMEPA1,PPP1CA,PPP1R15A,RHOA,RPS27A,STRAP,STUB1,UBC,UBE2M	
HIF1Î± Signaling	5.98E00	1.34E-01	-0.962	CDKN1A,COPS5,EDN1,EGLN2,EIF4E,EIF4EBP1,ELOC,HRAS,HSP90AA1,HSPA14,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,JUN,LDHA,MAPK3,MMP15,PDGFB,PKM,RACK1,RAN,RASD1,RPS6,RRAS,SAT1,STUB1,VIM	
RHOA Signaling	5.69E00	1.61E-01	-4.472	ACTB,ACTG1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,CDC42EP1,CDC42EP2,CDC42EP3,CFL1,CFL2,MYL12A,MYL12B,MYL6,PFN1,RDX,RHOA	
Macroautophagy	5.67E00	2.15E-01	-3.742	ATG101,CHMP2A,CHMP6,DYNLL1,GABARAP,GABARAPL2,LAMTOR2,LAMTOR3,MAP1LC3A,MAP1LC3B,PRKAB1,RHEB,RRAGA,WDR45B	
Regulation of Actin-based Motility by Rho	5.6E00	1.65E-01	-4.123	ACTB,ARHGDIA,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,Cdc42,CFL1,MYL12A,MYL12B,MYL6,PFN1,RHOA,RHOB,RHOC,RHOG	
RHOGDI Signaling	5.53E00	1.27E-01	3.411	ACTB,ACTG1,ARHGDIA,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,Cdc42,CDH5,CFL1,CFL2,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,MYL12A,MYL12B,MYL6,RDX,RHOA,RHOB,RHOC,RHOG	
14-3-3-mediated Signaling	5.52E00	1.57E-01	-2.714	BAD,BAX,FOS,HRAS,JUN,MAPK3,PDIA3,RASD1,RRAS,TUBA1A,TUBA1B,TUBA1C,TUBB,TUBB2A,TUBB2B,TUBB4B,VIM,YWHAE,YWHAH,YWHAQ	
Late endosomal microautophagy	5.52E00	2.94E-01	-3.162	CHMP2A,CHMP6,HSPA8,PARK7,PLIN3,RPS27A,UBC,VIM,VPS28,VPS37B	
Cargo recognition for clathrin-mediated endocytosis	5.45E00	1.68E-01	-4.243	ADRB2,AP2A2,Ap2b1,AP2M1,AP2S1,CLTA,CLTB,COPS5,COPS8,HBEGF,NECAP2,NEDD8,RPS27A,SH3GL1,TOR1A,UBC,VAMP3,VAMP8	
ESR-mediated signaling	5.42E00	1.61E-01	-4.359	CDK9,DDX5,FKBP4,FOS,HSP90AA1,HSP90AB1,JUN,JUND,MAPK3,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,PPID,PRMT1,PTGES3	
MicroRNA Biogenesis Signaling Pathway	5.39E00	1.34E-01	-4.600	DDX5,DNAJA2,HNRNPA2B1,HRAS,HSP90AA1,HSP90AB1,HSP90B1,HSPA8,ILF2,MAPK3,PDGFB,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,PTGES3,RAN,RASD1,RRAS,SEC13,SRSF3,ST13	
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane	5.3E00	3.64E-01	-2.828	CAMLG,CYB5A,EMD,PRNP,SEC61B,SEC61G,SGTA,VAPA	
TP53 Regulates Transcription of DNA Repair Genes	5.27E00	2E-01	-3.742	AP1S1,AP1S2,CDK9,ELOC,FOS,JUN,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,TCEA1	
HER-2 Signaling in Breast Cancer	5.27E00	1.23E-01	1.347	ARF1,Arf2,ARF4,ARF5,ARF6,BAD,CDKN1A,COX17,COX4I1,COX5A,COX6B1,Cox6c,COX7A2,COX7A2L,COX8A,CYB5A,FOS,HBEGF,HRAS,JUN,MAPK3,NFKBIA,RASD1,RHEB,RPS6,RRAS,SEC13,SURF1	
Cilium Assembly	5.19E00	1.27E-01	-5.000	ARF4,BBIP1,CCT2,CCT3,CCT4,CCT5,CCT7,CCT8,CETN2,CSNK1E,DCTN2,DCTN3,DYNLL1,DYNLRB1,HSP90AA1,IFT20,RAB11A,SSNA1,TUBA1A,TUBA1B,TUBA1C,TUBB,TUBB2A,TUBB2B,TUBB4B,YWHAE	
Coronavirus Replication Pathway	5.15E00	2.44E-01	-2.111	COPE,IFITM2,IFITM3,TUBA1A,TUBA1B,TUBA1C,TUBB,TUBB2A,TUBB2B,TUBB4B,ZCRB1	
Extra-nuclear estrogen signaling	5.05E00	1.92E-01	-3.742	CAV1,CAV2,FOS,GNAI2,GNB2,GNG11,GNG5,GNGT2,HBEGF,HRAS,HSP90AA1,HSPB1,MAPK3,PRMT1	
Actin Nucleation by ARP-WASP Complex	5.04E00	1.72E-01	-3.742	ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,Cdc42,HRAS,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,VASP	
Amino acids regulate mTORC1	5.01E00	2.18E-01	-3.464	ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,CASTOR1,LAMTOR2,LAMTOR3,RHEB,RRAGA,SEC13	
Ephrin Receptor Signaling	4.8E00	1.24E-01	-4.690	ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,ATF4,CFL1,CFL2,CREB3,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,PDGFA,PDGFB,RASD1,RHOA,RRAS,SDCBP	
Iron uptake and transport	4.76E00	2.07E-01	-3.464	ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,FTH1,FTL,GLRX3,NEDD8,RPS27A,UBC	
fMLP Signaling in Neutrophils	4.75E00	1.45E-01	-3.500	ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,Calm1 (includes others),GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,NFKBIA,RASD1,RRAS	
Germ Cell-Sertoli Cell Junction Signaling	4.6E00	1.29E-01	NaN	ACTB,ACTG1,Cdc42,CFL1,CFL2,HRAS,ILK,JUP,MAPK3,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,TUBA1A,TUBA1B,TUBA1C,TUBB,TUBB2A,TUBB2B,TUBB4B	
Immunogenic Cell Death Signaling Pathway	4.6E00	1.67E-01	-3.873	ATF4,BAX,BCAP31,DAPK3,DDIT3,HSP90AA1,HSP90AB1,HSP90B1,HSPA14,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,IFNGR1,PDIA3	
Role of PKR in Interferon Induction and Antiviral Response	4.52E00	1.4E-01	0.471	ATF3,BAX,CYCS,FOS,HSP90AA1,HSP90AB1,HSP90B1,HSPA14,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,IFNGR1,JUN,MAPK3,NFKBIA,NPM1,PDGFA,PDGFB	
Translocation of SLC2A4 (GLUT4) to the plasma membrane	4.51E00	1.83E-01	-3.606	ACTB,ACTG1,PRKAB1,RAB11A,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B,YWHAE,YWHAH,YWHAQ	
MTOR signalling	4.42E00	2.86E-01	-2.828	EIF4E,EIF4EBP1,FKBP1A,LAMTOR2,LAMTOR3,RHEB,RPS6,RRAGA	
RHO GTPases activate PKNs	4.42E00	2.86E-01	-2.828	MYL12B,MYL6,RHOA,RHOB,RHOC,YWHAE,YWHAH,YWHAQ	
Axonal Guidance Signaling	4.41E00	9.02E-02	NaN	ADAMTS1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,CFL1,CFL2,COPS5,EIF3F,EIF3H,EIF4E,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,MMP15,MYL12A,MYL12B,MYL6,PDGFA,PDGFB,PDIA3,PFN1,PLXND1,PMPCB,PRKAR1A,RASD1,RHOA,RRAS,RTN4,SDCBP,TUBA1A,TUBA1B,TUBA1C,TUBB,TUBB2A,TUBB2B,TUBB4B,VASP	
RHO GTPases Activate WASPs and WAVEs	4.4E00	2.5E-01	-3.000	ACTB,ACTG1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,MAPK3	
Signaling by FGFR2	4.37E00	1.78E-01	-3.606	HNRNPF,HNRNPM,HRAS,MAPK3,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,RPS27A,UBC	
Response of EIF2AK1 (HRI) to heme deficiency	4.36E00	4E-01	-2.449	ATF3,ATF4,CEBPG,DDIT3,EIF2S2,PPP1R15A	
Detoxification of Reactive Oxygen Species	4.29E00	2.43E-01	-3.000	ATOX1,CYBA,CYCS,GPX1,PRDX1,PRDX2,PRDX6,TXN,TXN2	
Gene and protein expression by JAK-STAT signaling after IL-12 stimulation	4.29E00	2.43E-01	1.000	ANXA2,ARF1,CFL1,CNN2,HNRNPA2B1,HNRNPF,PPIA,RPLP0,TALDO1	
Protein Sorting Signaling Pathway	4.29E00	1.24E-01	-4.690	AP1S1,AP1S2,ARF1,CLTA,CLTB,COPE,GNAS,KDELR1,PRKAR1A,RAB11A,RER1,SEC13,SERPINH1,SNX15,SNX17,SNX3,TMED10,TMED2,TMED4,TMED5,TMED9,VPS29	
Virus Entry via Endocytic Pathways	4.28E00	1.44E-01	NaN	ACTB,ACTG1,AP1S1,AP1S2,AP2A2,Ap2b1,AP2M1,AP2S1,CAV1,CLTA,CLTB,HLA-A,HLA-E,HLA-G,HRAS,RASD1,RRAS	
ATF6 (ATF6-alpha) activates chaperone genes	4.27E00	5E-01	-2.236	ATF4,DDIT3,HSP90B1,HSPA5,XBP1	
Intrinsic Pathway for Apoptosis	4.27E00	2E-01	-3.317	BAD,BAX,BBC3,C1QBP,CYCS,DYNLL1,MAPK3,NMT1,YWHAE,YWHAH,YWHAQ	
The citric acid (TCA) cycle and respiratory electron transport	4.27E00	2E-01	-3.317	BSG,FH,IDH3G,LDHA,MDH2,MPC1,PDHB,SDHB,SDHD,SUCLG1,VDAC1	
CLEAR Signaling Pathway	4.25E00	1.05E-01	2.043	ATF4,ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,BLOC1S1,CASTOR1,CREB3,GABARAP,GLMP,HRAS,LAMP1,LAMTOR2,LAMTOR3,MAPK3,PDGFB,PIP4P1,PPP2R2D,PRKAB1,RASD1,RHEB,RRAGA,RRAS,SEC13,STUB1,YWHAE,YWHAH,YWHAQ	
Necroptosis Signaling Pathway	4.22E00	1.29E-01	-4.025	FKBP1A,PPID,SLC25A3,SLC25A4,SLC25A5,TIMM13,TIMM17A,TIMM23,TIMM50,TIMM8B,TOMM20,TOMM22,TOMM40,TOMM6,TOMM7,TSPO,UBC,VDAC1,VDAC2,VDAC3	
Synaptogenesis Signaling Pathway	4.19E00	1.02E-01	-3.780	AP2A2,Ap2b1,AP2M1,AP2S1,APOE,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,ATF4,BAD,Calm1 (includes others),CDH5,CFL1,CREB3,EIF4EBP1,HRAS,HSPA8,MAPK3,NAP1L4,NAPA,PRKAR1A,RAB5A,RASD1,RHOA,RRAS,SGTA,VAMP3,VTI1B	
Androgen Signaling	4.16E00	1.24E-01	-2.236	Calm1 (includes others),GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,GTF2B,H3-3A/H3-3B,HSP90AA1,JUN,MAPK3,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,PRKAR1A,TGFB1I1	
Epithelial Adherens Junction Signaling	4.1E00	1.27E-01	-2.065	ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,CFL1,CFL2,HRAS,MYL12A,MYL12B,PPP2R2D,PRKAB1,RASD1,RHOA,RRAS,YWHAE,YWHAH,YWHAQ	
RHO GTPases activate IQGAPs	4.07E00	2.58E-01	-2.828	ACTB,ACTG1,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B	
Protein Kinase A Signaling	3.97E00	9.25E-02	-0.354	AKAP12,ANAPC11,ATF4,BAD,Calm1 (includes others),CREB3,CREM,DUSP1,DUSP11,DUSP8,GDE1,GNAI2,GNAS,GNB2,GNG11,GNG5,H3-3A/H3-3B,KDELR1,MAPK3,MYL12A,MYL12B,MYL6,NFKBIA,PDIA3,PGP,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B,PRKAR1A,PTPRR,RHOA,SMPDL3A,TIMM50,VASP,YWHAE,YWHAH,YWHAQ	
L1CAM interactions	3.96E00	1.36E-01	-4.123	ACTB,ACTG1,AP2A2,AP2M1,AP2S1,CLTA,CSNK2B,HSPA8,MAPK3,RDX,SDCBP,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B	
NER (Nucleotide Excision Repair, Enhanced Pathway)	3.94E00	1.54E-01	-2.496	CETN2,COPS5,COPS8,HMGN1,NEDD8,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,TCEA1,UBE2I	
ILK Signaling	3.93E00	1.14E-01	-4.359	ACTB,ACTG1,ATF4,Cdc42,CFL1,CFL2,CREB3,FERMT2,FOS,ILK,JUN,LIMS2,MAPK3,MYL6,NACA,PPP1R14B,PPP2R2D,RHOA,RHOB,RHOC,RHOG,TGFB1I1,VIM	
Sumoylation Pathway	3.9E00	1.46E-01	0.000	ARHGDIA,Cdc42,FOS,JUN,NFKBIA,RAN,RHOA,RHOB,RHOC,RHOG,STUB1,SUMO1,SUMO2,SUMO3,UBE2I	
Signal amplification	3.86E00	2.42E-01	-2.828	AAMP,GNA11,GNAI2,GNB2,GNG11,GNG5,GNGT2,TBXA2R	
Ephrin B Signaling	3.79E00	1.67E-01	-2.646	CFL1,CFL2,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HNRNPK,HRAS,MAPK3,RHOA	
FcÎ³ Receptor-mediated Phagocytosis in Macrophages and Monocytes	3.78E00	1.49E-01	-3.742	ACTB,ACTG1,ARF6,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,MAPK3,RAB11A,VAMP3,VASP	
RHO GTPase cycle	3.78E00	8.89E-02	-6.325	ACTB,ACTG1,AKAP12,ARHGDIA,BCAP31,C1QBP,CAV1,CCDC115,CCT2,CCT7,CDC42EP1,CDC42EP2,CDC42EP3,CKB,CYBA,DDRGK1,DDX39B,EMC3,EMD,FERMT2,HSP90AA1,HSP90AB1,HSPE1,JUP,NDUFA5,NDUFS3,NUDC,PLXND1,RHOA,RHOB,RHOC,RHOG,STIP1,SWAP70,TMEM59,TMOD3,TRIP10,TUBA1B,VAMP3,VIM	
Hereditary Breast Cancer Signaling	3.76E00	1.27E-01	NaN	ACTB,CDKN1A,GADD45B,GADD45G,HRAS,NPM1,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,RASD1,RPS27A,RRAS,Ubb,UBC	
CXCR4 Signaling	3.73E00	1.19E-01	-3.873	Cdc42,FOS,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,JUN,MAPK3,MYL12A,MYL12B,MYL6,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
RHO GTPases Activate ROCKs	3.7E00	3.16E-01	-2.449	CFL1,MYL12B,MYL6,RHOA,RHOB,RHOC	
trans-Golgi Network Vesicle Budding	3.68E00	1.62E-01	-3.464	AP1S1,AP1S2,ARF1,BLOC1S1,CHMP2A,CLTA,CLTB,FTH1,FTL,HSPA8,NAPA,VAMP8	
IL-8 Signaling	3.65E00	1.1E-01	-3.638	BAX,Cdc42,EIF4EBP1,FOS,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HBEGF,HRAS,JUN,MAPK3,MYL12B,NFKBIA,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,VASP	
Dissolution of Fibrin Clot	3.61E00	3.85E-01	-2.236	ANXA2,PLAT,PLAUR,S100A10,SERPINB6	
Mitochondrial calcium ion transport	3.61E00	3.85E-01	-2.236	MCUB,SMDT1,VDAC1,VDAC2,VDAC3	
mRNA Capping	3.43E00	2.41E-01	-2.646	POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K	
Renal Cell Carcinoma Signaling	3.41E00	1.52E-01	-2.236	ELOC,FH,FOS,HRAS,JUN,MAPK3,PDGFB,RASD1,RPS27A,RRAS,Ubb,UBC	
RHO GTPases Activate Formins	3.4E00	1.22E-01	-4.123	ACTB,ACTG1,BUB3,DYNLL1,NDEL1,NUDC,PFN1,RHOA,RHOB,RHOC,SEC13,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B	
Insulin Secretion Signaling Pathway	3.4E00	9.82E-02	-4.811	ATF4,CREB3,EIF2B4,EIF2S2,EIF4A1,EIF4A3,EIF4E,EIF4EBP1,GNA11,GNAS,MAPK3,NAPA,PDHB,PDIA3,PRKAR1A,SEC11A,SEC11C,SEC61B,SEC61G,SPCS2,SRP14,SRP19,SRP9,SSR2,SSR4,VAMP3,VTI1B	
Cardiac Hypertrophy Signaling	3.39E00	9.96E-02	-3.962	ADRB2,Calm1 (includes others),Cdc42,EIF2B4,EIF4E,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,HSPB1,JUN,MAPK3,MYL12A,MYL12B,MYL6,PDIA3,PRKAR1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
NGF-stimulated transcription	3.33E00	2.05E-01	-2.646	FOS,ID1,ID2,ID3,JUNB,JUND,LYL1,SGK1	
Metabolism of nitric oxide: NOS3 activation and regulation	3.28E00	3.33E-01	-2.236	CAV1,DDAH2,HSP90AA1,NOSTRIN,SPR	
IGF-1 Signaling	3.28E00	1.33E-01	-1.667	BAD,CCN1,CSNK2B,FOS,HRAS,JUN,MAPK3,PRKAR1A,RASD1,RRAS,SOCS2,YWHAE,YWHAH,YWHAQ	
RHO GTPases Activate Rhotekin and Rhophilins	3.25E00	4.44E-01	-2.000	RHOA,RHOB,RHOC,TAX1BP3	
Endosomal Sorting Complex Required For Transport (ESCRT)	3.24E00	2.26E-01	-2.646	CHMP2A,CHMP5,CHMP6,RPS27A,UBC,VPS28,VPS37B	
TCA Cycle II (Eukaryotic)	3.2E00	2.61E-01	-2.449	FH,IDH3G,MDH2,SDHB,SDHD,SUCLG1	
PPAR Signaling	3.19E00	1.31E-01	2.496	FOS,HRAS,HSP90AA1,HSP90AB1,HSP90B1,JUN,MAPK3,NFKBIA,PDGFA,PDGFB,RASD1,RRAS,SNW1,SRA1	
Cytoprotection by HMOX1	3.14E00	1.61E-01	-3.162	COX20,COX4I1,COX5A,COX6B1,COX7A2L,COX8A,CYCS,NDUFA4,NFE2L2,SURF1	
ERK5 Signaling	3.09E00	1.49E-01	-2.530	ATF4,BAD,CREB3,FOS,HRAS,RASD1,RRAS,SGK1,YWHAE,YWHAH,YWHAQ	
Spliceosomal Cycle	3.04E00	1.7E-01	-3.000	BCAS2,CWC15,DDX39B,EIF4A3,HSPA8,PPIE,RBM8A,SF3B4,SF3B6	
Signaling by Insulin receptor	3.03E00	1.86E-01	-2.828	ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,HRAS,MAPK3	
Semaphorin interactions	3.03E00	1.56E-01	-3.162	CFL1,HSP90AA1,HSP90AB1,MYL12B,MYL6,PLXND1,RHOA,RHOB,RHOC,RRAS	
Plasma lipoprotein assembly, remodeling, and clearance	2.99E00	1.45E-01	-3.317	AP2A2,AP2M1,AP2S1,APOE,CLTA,LSR,NR1H2,PLTP,RPS27A,SAR1B,UBC	
SUMOylation of transcription cofactors	2.96E00	1.82E-01	-2.828	DDX5,NPM1,PARK7,PHC2,SUMO1,SUMO2,SUMO3,UBE2I	
E3 ubiquitin ligases ubiquitinate target proteins	2.92E00	1.64E-01	-3.000	BCL10,HLA-A,RNF181,RPS27A,RRAGA,UBC,UBE2A,UBE2B,UBE2D3	
Role of MAPK Signaling in Promoting the Pathogenesis of Influenza	2.92E00	1.23E-01	-3.051	ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,BAX,HRAS,JUN,MAPK3,NFKBIA,PRDX6,RASD1,RRAS	
Nucleotide Excision Repair Pathway	2.91E00	2E-01	NaN	POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K	
Beta-catenin independent WNT signaling	2.9E00	1.27E-01	-3.606	AP2A2,AP2M1,AP2S1,CLTA,CLTB,GNB2,GNG11,GNG5,GNGT2,PFN1,RHOA,RPS27A,UBC	
GPER1 signaling	2.9E00	1.78E-01	-2.828	GNAI2,GNAS,GNB2,GNG11,GNG5,GNGT2,GPER1,PRKAR1A	
Unfolded Protein Response (UPR)	2.88E00	2.78E-01	-2.236	ATF4,CREB3,EIF2S2,HSPA5,XBP1	
Processing and activation of SUMO	2.87E00	3.64E-01	-2.000	SUMO1,SUMO2,SUMO3,UBE2I	
SUMOylation of immune response proteins	2.87E00	3.64E-01	-2.000	NFKBIA,SUMO1,SUMO3,UBE2I	
Pexophagy	2.87E00	3.64E-01	-2.000	MAP1LC3B,RPS27A,SQSTM1,UBC	
RHO GTPases activate CIT	2.76E00	2.63E-01	-2.236	MYL12B,MYL6,RHOA,RHOB,RHOC	
PI3K/AKT Signaling	2.76E00	1E-01	-2.840	BAD,CDKN1A,EIF4E,EIF4EBP1,HRAS,HSP90AA1,HSP90AB1,HSP90B1,IL10RB,ILK,MAPK3,MCL1,NFKBIA,PPP2R2D,RASD1,RHEB,RRAS,YWHAE,YWHAH,YWHAQ	
Aldosterone Signaling in Epithelial Cells	2.76E00	1.05E-01	NaN	DNAJA1,DNAJB11,DNAJB2,DUSP1,HSP90AA1,HSP90AB1,HSP90B1,HSPA14,HSPA1A/HSPA1B,HSPA5,HSPA8,HSPB1,HSPD1,HSPE1,HSPH1,MAPK3,PDIA3,SGK1	
Actin Cytoskeleton Signaling	2.75E00	9.43E-02	-3.578	ACTB,ACTG1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,CFL1,CFL2,HRAS,MAPK3,MYL12A,MYL12B,MYL6,PDGFA,PDGFB,PFN1,RASD1,RDX,RHOA,RRAS	
Response to elevated platelet cytosolic Ca2+	2.74E00	1.14E-01	-3.873	ALDOA,ANXA5,CD9,CFL1,HSPA5,MANF,PDGFA,PDGFB,PFN1,PPIA,SPARC,TAGLN2,TEX264,VTI1B,WDR1	
Autophagy	2.7E00	9.68E-02	-3.900	ATF4,ATG101,BAD,Calm1 (includes others),CREB3,DAPK3,DDIT3,FOS,GABARAP,GABARAPL2,JUN,LAMP1,MAP1LC3A,MAP1LC3B,MAPK3,PDGFB,PPP2R2D,PRKAB1,PRKAR1A,SQSTM1,VAMP8	
Mitotic Prometaphase	2.69E00	9.85E-02	-4.472	BUB3,CETN2,CSNK1E,CSNK2B,DCTN2,DCTN3,DYNLL1,HSP90AA1,NDEL1,NUDC,SEC13,SSNA1,TUBA1A,TUBA1B,TUBA1C,TUBB,TUBB2A,TUBB2B,TUBB4B,YWHAE	
ISG15 antiviral mechanism	2.68E00	1.41E-01	-3.162	EIF4A1,EIF4A3,EIF4E,EIF4E2,ISG15,MAPK3,PIN1,RPS27A,SEC13,UBC	
Interferon alpha/beta signaling	2.68E00	1.41E-01	-3.162	HLA-A,HLA-E,HLA-G,IFI35,IFITM2,IFITM3,IRF7,ISG15,RSAD2,XAF1	
RNA polymerase II transcribes snRNA genes	2.67E00	1.33E-01	-3.317	CDK9,GTF2B,PHAX,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,SNAPC5	
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	2.65E00	1.63E-01	-2.121	CDK8,CDK9,JUNB,MAPK3,RPS27A,SNW1,UBC,YBX1	
Formaldehyde Oxidation II (Glutathione-dependent)	2.63E00	1E00	NaN	ADH5,ESD	
COPII-mediated vesicle transport	2.63E00	1.39E-01	-3.162	CNIH1,NAPA,SAR1B,SEC13,TMED10,TMED2,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6B	
Gap Junction Signaling	2.63E00	8.62E-02	-3.780	ACTB,ACTG1,ATF4,Calm1 (includes others),CAV1,CREB3,CSNK1E,GNAI2,GNAS,HRAS,HSPA8,MAPK3,NT5C,PDIA3,PRKAR1A,RASD1,RRAS,TUBA1A,TUBA1B,TUBA1C,TUBB,TUBB2A,TUBB2B,TUBB4B,VDAC1,VDAC2,VDAC3,YBX3	
Antigen Presentation Pathway	2.62E00	1.79E-01	NaN	HLA-A,HLA-E,HLA-G,PDIA3,PSMB5,PSMB6,TAP2	
Sertoli Cell-Germ Cell Junction Signaling Pathway (Enhanced)	2.59E00	9.32E-02	-1.706	ACTB,ACTG1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,CLDN5,F11R,FOS,HRAS,ILK,JUN,JUP,MAPK3,PPP2R2D,PRKAB1,PRKAR1A,RASD1,RRAS	
Signaling by NOTCH3	2.59E00	1.6E-01	-2.828	HES1,HEY1,PLXND1,PSENEN,RPS27A,SNW1,UBC,YBX1	
Assembly of RNA Polymerase II Complex	2.59E00	1.6E-01	-2.828	GTF2B,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K	
Glioma Invasiveness Signaling	2.58E00	1.37E-01	-2.828	Cdc42,HRAS,MAPK3,PLAUR,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
RAC Signaling	2.58E00	1.09E-01	-3.742	ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,CFL1,CFL2,HRAS,JUN,MAPK3,RASD1,RHOA,RRAS	
Processing of SMDT1	2.56E00	3.08E-01	-2.000	MCUB,PHB2,PMPCB,SMDT1	
Protein ubiquitination	2.56E00	2E-01	-2.449	RPS27A,UBC,UBE2A,UBE2B,UBE2G2,UBE2S	
Endoplasmic Reticulum Stress Pathway	2.56E00	2.38E-01	-2.236	ATF4,DDIT3,HSP90B1,HSPA5,XBP1	
UFMylation Signaling Pathway	2.55E00	1.45E-01	-3.000	DDRGK1,EIF4A1,EIF4A3,EIF4E,GPX4,H3-3A/H3-3B,RPL26,UFM1,XBP1	
RNA Polymerase III Transcription	2.49E00	1.71E-01	-2.646	GTF3C6,POLR1D,POLR2E,POLR2F,POLR2K,SNAPC5,SSB	
Mechanisms of Viral Exit from Host Cells	2.49E00	1.71E-01	NaN	ACTB,ACTG1,CHMP2A,CHMP6,SH3GL1,SH3GLB1,VPS28	
Insulin Receptor Signaling	2.49E00	1.07E-01	-2.309	BAD,EIF2B4,EIF4E,EIF4EBP1,HRAS,MAPK3,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B,PRKAR1A,RASD1,RRAS,SGK1,TRIP10	
Apelin Endothelial Signaling Pathway	2.46E00	1.06E-01	-3.162	Calm1 (includes others),FOS,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,JUN,KLF2,MAPK3,PRKAB1,RASD1,RRAS	
Sleep NREM Signaling Pathway	2.43E00	1.13E-01	3.051	ADRB2,ATF4,CREB3,GNAI2,GNAS,HRAS,MAPK3,PRKAR1A,RASD1,RRAS,YWHAE,YWHAH,YWHAQ	
Thrombin signalling through proteinase activated receptors (PARs)	2.41E00	1.88E-01	-2.449	GNA11,GNB2,GNG11,GNG5,GNGT2,MAPK3	
G Beta Gamma Signaling	2.41E00	1.09E-01	-3.464	CAV1,CAV2,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HBEGF,HRAS,MAPK3,PRKAR1A,RASD1,RRAS	
ERK/MAPK Signaling	2.4E00	9.3E-02	-1.000	ATF4,BAD,CREB3,DUSP1,EIF4E,EIF4EBP1,FOS,H3-3A/H3-3B,HRAS,HSPB1,LAMTOR3,MAPK3,PPP1CA,PPP1R11,PPP1R14B,PRKAR1A,RASD1,RRAS,YWHAH,YWHAQ	
Vasopressin regulates renal water homeostasis via Aquaporins	2.37E00	1.63E-01	-2.646	GNAS,GNB2,GNG11,GNG5,GNGT2,PRKAR1A,RAB11A	
Chaperone Mediated Autophagy Signaling Pathway	2.37E00	7.24E-02	0.295	ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,BAG1,BBC3,EEF1A1,EIF4A1,EIF4H,GPX4,HSP90AA1,HSP90AB1,HSP90B1,HSPA14,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,MCL1,MMP15,NFE2L2,NFKBIA,PARK7,PLIN3,PRKAB1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSME1,RAB11A,STIP1,STUB1,TPT1	
Ceramide Signaling	2.36E00	1.21E-01	-2.828	BAD,CYCS,FOS,HRAS,JUN,MAPK3,PPP2R2D,RASD1,RRAS,S1PR1,SMPD2	
Synaptic Long Term Potentiation	2.32E00	1.06E-01	-1.387	ATF4,Calm1 (includes others),CREB3,GNA11,HRAS,MAPK3,PDIA3,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B,PRKAR1A,RASD1,RRAS	
GABA Receptor Signaling	2.32E00	1.06E-01	NaN	AP2A2,Ap2b1,AP2M1,AP2S1,GABARAP,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,RPS27A,Ubb,UBC	
Cell junction organization	2.32E00	1.2E-01	-3.317	ACTB,ACTG1,CD151,CDH5,CLDN5,F11R,FERMT2,ILK,JUP,LIMS2,VASP	
TBC/RABGAPs	2.32E00	1.59E-01	-2.646	ARF6,GABARAP,GABARAPL2,MAP1LC3B,RAB11A,RAB5A,TBC1D10A	
Opioid Signaling Pathway	2.31E00	8.57E-02	-2.524	AP2A2,Ap2b1,AP2M1,AP2S1,ATF4,BAD,Calm1 (includes others),CLTA,CLTB,CREB3,FOS,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,NFKBIA,OGFR,PRKAR1A,RASD1,RRAS	
P2Y Purigenic Receptor Signaling Pathway	2.29E00	1.05E-01	-2.887	ATF4,CREB3,FOS,GNAI2,GNB2,GNG11,GNG5,HRAS,JUN,MAPK3,PDIA3,PRKAR1A,RASD1,RRAS	
RAS processing	2.29E00	2.08E-01	-2.236	ABHD17A,FNTA,HRAS,RPS27A,UBC	
CCR3 Signaling in Eosinophils	2.26E00	1.04E-01	-2.000	Calm1 (includes others),CFL1,CFL2,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,RASD1,RHOA,RRAS	
Carboxyterminal post-translational modifications of tubulin	2.26E00	1.56E-01	-2.646	TPGS1,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B	
Chemokine Signaling	2.25E00	1.23E-01	-2.333	Calm1 (includes others),CFL1,FOS,GNAI2,HRAS,JUN,MAPK3,RASD1,RHOA,RRAS	
Î±-Adrenergic Signaling	2.19E00	1.1E-01	-2.449	Calm1 (includes others),GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,PRKAR1A,RASD1,RRAS	
SUMOylation of nuclear envelope proteins	2.17E00	6.67E-01	NaN	SUMO1,UBE2I	
NADH Repair	2.17E00	6.67E-01	NaN	GAPDH,NAXE	
S-adenosyl-L-methionine Biosynthesis	2.17E00	6.67E-01	NaN	MAT2A,MAT2B	
Iron homeostasis signaling pathway	2.15E00	1.01E-01	NaN	ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,CIAO2B,FTH1,FTL,ISCU,MAPK3,PCBP1,PDGFA,PDGFB	
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	2.15E00	1.67E-01	-0.816	APOE,CDKN1A,HSPD1,NPM1,SUMO1,UBE2I	
Interferon Signaling	2.15E00	1.67E-01	-2.449	BAX,IFI35,IFITM2,IFITM3,IFNGR1,ISG15	
Activation of NMDA receptors and postsynaptic events	2.14E00	1.19E-01	-3.162	HRAS,MAPK3,PRKAB1,PRKAR1A,TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B	
Signaling by ERBB4	2.14E00	1.36E-01	-2.828	APOE,HBEGF,HRAS,PSENEN,RPS27A,SPARC,STMN1,UBC	
Polyamine Regulation in Colon Cancer	2.14E00	1.36E-01	-1.414	CSNK2B,EIF5A,FOS,JUN,MAPK3,OAZ1,RHOA,SAT1	
Sertoli Cell-Sertoli Cell Junction Signaling	2.13E00	8.64E-02	-4.583	ACTB,ACTG1,ATF4,CDH5,CLDN5,CREB3,F11R,HRAS,JUN,JUP,MAPK3,RASD1,RRAS,TUBA1A,TUBA1B,TUBA1C,TUBB,TUBB2A,TUBB2B,TUBB4B,YBX3	
Serotonin Receptor Signaling	2.12E00	7.46E-02	-4.902	ADRB2,ATF4,Calm1 (includes others),CAV1,CAV2,Cdc42,COPS5,CREB3,EDN1,EIF4EBP1,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,H3-3A/H3-3B,HRAS,JUN,MAP1LC3B,MAPK3,NFKBIA,ORAI1,PDIA3,PLAUR,PRDX6,PRKAR1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,SPR,SQSTM1	
Lipophagy	2.12E00	3.33E-01	NaN	HSPA8,PLIN3,PRKAB1	
FOXO-mediated transcription of cell cycle genes	2.11E00	2.35E-01	-2.000	BTG1,CAV1,CDKN1A,KLF4	
Apelin Muscle Signaling Pathway	2.1E00	1.46E-01	NaN	GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,PRKAB1	
GÎ±i Signaling	2.1E00	1E-01	-2.530	CAV1,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,PRKAR1A,RASD1,RRAS,S1PR1,TBXA2R	
MSP-RON Signaling in Cancer Cells Pathway	2.1E00	1E-01	-3.207	ATF4,CREB3,FOS,HRAS,JUN,MAPK3,NFKBIA,PLAUR,RASD1,RRAS,VIM,YWHAE,YWHAH,YWHAQ	
ATF4 activates genes in response to endoplasmic reticulum stress	2.06E00	1.85E-01	-2.236	ATF3,ATF4,CEBPG,DDIT3,HERPUD1	
Glycolysis I	2.06E00	1.85E-01	-2.236	ALDOA,GAPDH,PFKL,PGAM1,PKM	
eNOS Signaling	2.06E00	9.62E-02	1.265	Calm1 (includes others),CAV1,GNAS,HSP90AA1,HSP90AB1,HSP90B1,HSPA14,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,NOSTRIN,PRKAB1,PRKAR1A,STUB1	
Semaphorin Signaling in Neurons	2.06E00	1.31E-01	NaN	Cdc42,CFL1,CFL2,MAPK3,RHOA,RHOB,RHOC,RHOG	
p75 NTR receptor-mediated signalling	2.05E00	1.1E-01	-3.317	ARHGDIA,BAD,NFKBIA,PSENEN,RHOA,RPS27A,RTN4,SMPD2,SQSTM1,UBC,YWHAE	
Prostate Cancer Signaling	2.04E00	1.05E-01	NaN	ATF4,BAD,CDKN1A,CREB3,HRAS,HSP90AA1,HSP90AB1,HSP90B1,MAPK3,NFKBIA,RASD1,RRAS	
HIPPO signaling	2.04E00	1.15E-01	1.000	CSNK1E,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B,PPP2R2D,RASSF1,YWHAE,YWHAH,YWHAQ	
PDGF Signaling	2.04E00	1.15E-01	-2.333	CAV1,CSNK2B,FOS,HRAS,JUN,MAPK3,PDGFA,PDGFB,RASD1,RRAS	
Signaling by ERBB2	2.01E00	1.4E-01	-2.646	HBEGF,HRAS,HSP90AA1,RHOA,RPS27A,STUB1,UBC	
SUMOylation of intracellular receptors	1.99E00	1.79E-01	-2.236	NR1H2,SUMO1,SUMO2,SUMO3,UBE2I	
Glutathione Redox Reactions I	1.99E00	1.79E-01	-2.236	GPX1,GPX4,GSTM2,MGST3,PRDX6	
Aryl Hydrocarbon Receptor Signaling	1.99E00	9.43E-02	0.302	ALDH2,BAX,CDKN1A,FOS,GSTM2,HSP90AA1,HSP90AB1,HSP90B1,HSPB1,JUN,MAPK3,MGST3,NEDD8,NFE2L2,PTGES3	
SUMOylation of DNA damage response and repair proteins	1.96E00	1.18E-01	-3.000	CETN2,NSMCE3,NSMCE4A,PHC2,SEC13,SUMO1,SUMO2,SUMO3,UBE2I	
UVC-Induced MAPK Signaling	1.96E00	1.37E-01	-2.449	FOS,HRAS,JUN,MAPK3,RASD1,RRAS,SMPD2	
PAK Signaling	1.96E00	1.03E-01	-2.333	CFL1,CFL2,HRAS,MAPK3,MYL12A,MYL12B,MYL6,PAK1IP1,PDGFA,PDGFB,RASD1,RRAS	
Circadian Rhythm Signaling	1.95E00	8.21E-02	NaN	ATF4,CIRBP,CREB3,CSNK1E,EIF4E,EIF4EBP1,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,H3-3A/H3-3B,HRAS,MAPK3,NT5C,PDIA3,PRKAB1,PRKAR1A,RACK1,RASD1,RRAS	
GNRH Signaling	1.94E00	8.9E-02	-3.742	ATF4,Calm1 (includes others),CREB3,FOS,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HBEGF,HRAS,JUN,MAPK3,PRKAR1A,RASD1,RRAS	
NFE2L2 regulating anti-oxidant/detoxification enzymes	1.93E00	2.11E-01	-2.000	ATF4,GCLM,NFE2L2,PRDX1	
Antiproliferative Role of Somatostatin Receptor 2	1.93E00	1.17E-01	-1.633	CDKN1A,GNB2,GNG11,GNG5,HRAS,MAPK3,NT5C,RASD1,RRAS	
Energy dependent regulation of mTOR by LKB1-AMPK	1.93E00	1.72E-01	-2.236	LAMTOR2,LAMTOR3,PRKAB1,RHEB,RRAGA	
UVB-Induced MAPK Signaling	1.92E00	1.35E-01	-2.449	BAD,EIF4E,EIF4EBP1,FOS,H3-3A/H3-3B,JUN,MAPK3	
Apelin Adipocyte Signaling Pathway	1.91E00	1.1E-01	-2.530	GNA11,GNAI2,GPX1,GPX4,GSTM2,MAPK3,MGST3,PRDX6,PRKAB1,PRKAR1A	
Colorectal Cancer Metastasis Signaling	1.9E00	8.12E-02	-3.153	BAD,BAX,Cdc42,FOS,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,IFNGR1,JUN,MAPK3,MMP15,PRKAR1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
Cholecystokinin/Gastrin-mediated Signaling	1.9E00	1.01E-01	-3.162	Cdc42,CREM,FOS,HRAS,JUN,MAPK3,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
Thrombin Signaling	1.88E00	8.44E-02	-3.162	Cdc42,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,MYL12A,MYL12B,MYL6,PDIA3,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
Sphingosine-1-phosphate Signaling	1.87E00	1E-01	-3.317	Cdc42,GNAI2,MAPK3,PDGFA,PDGFB,PDIA3,RHOA,RHOB,RHOC,RHOG,S1PR1,SMPD2	
Signaling by CSF3 (G-CSF)	1.87E00	1.67E-01	-2.236	ELOC,RNF7,RPS27A,UBC,UBE2D3	
DDX58/IFIH1-mediated induction of interferon-alpha/beta	1.86E00	1.14E-01	-3.000	HSP90AA1,HSP90AB1,IRF7,ISG15,NFKBIA,PIN1,RPS27A,UBC,UBE2D3	
Tight Junction Signaling	1.85E00	8.89E-02	NaN	ACTB,ACTG1,CLDN5,F11R,FOS,JUN,MYL6,NAPA,PPP2R2D,PRKAR1A,RHOA,VAMP3,VAPA,VASP,VTI1B,YBX3	
SUMOylation of transcription factors	1.85E00	2E-01	-2.000	SUMO1,SUMO2,SUMO3,UBE2I	
Synthesis, secretion, and deacylation of Ghrelin	1.85E00	2E-01	-2.000	KLF4,SEC11A,SEC11C,SPCS2	
Signaling by VEGF	1.81E00	1.02E-01	-3.317	AAMP,ACTB,ACTG1,CAV1,CDH5,CYBA,HRAS,HSP90AA1,HSPB1,JUP,RHOA	
Activation of anterior HOX genes in hindbrain during early embryogenesis	1.79E00	1.11E-01	-3.000	DPY30,JUN,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K	
Metabolism of non-coding RNA	1.79E00	1.27E-01	-2.646	GEMIN7,PHAX,SEC13,SNRPB,SNRPD1,SNRPD3,SNRPF	
Gene Silencing by RNA	1.78E00	1.05E-01	-3.162	HSP90AA1,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,RAN,SEC13	
Assembly and cell surface presentation of NMDA receptors	1.78E00	1.4E-01	-2.449	TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B	
FLT3 Signaling in Hematopoietic Progenitor Cells	1.76E00	1.1E-01	-1.414	ATF4,BAD,CREB3,EIF4E,EIF4EBP1,HRAS,MAPK3,RASD1,RRAS	
IL-10 Signaling	1.76E00	9.09E-02	0.000	ATF4,CDKN1A,CREB3,DUSP1,FOS,HLA-A,HLA-E,HLA-G,IFNGR1,IL10RB,JUN,NFKBIA,PKM,PRKAB1	
IL-1 Signaling	1.76E00	1.04E-01	-2.236	FOS,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,JUN,NFKBIA,PRKAR1A	
Eicosanoid Signaling	1.75E00	7.86E-02	-4.264	AP1S1,AP1S2,ATF4,BAD,CREB3,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,HSPB1,KLF4,MAPK3,PDIA3,PRDX6,PRKAR1A,RASD1,RHOA,RRAS,TBXA2R	
G-protein beta:gamma signalling	1.75E00	1.56E-01	-2.236	GNB2,GNG11,GNG5,GNGT2,RHOA	
RIPK1-mediated regulated necrosis	1.75E00	1.56E-01	-2.236	HSP90AA1,RPS27A,SDCBP,STUB1,UBC	
CGAS-STING Signaling Pathway	1.74E00	9.29E-02	-3.051	ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,BAX,CDKN1A,LRRC8A,MAP1LC3A,MAP1LC3B,NFKBIA,TNFSF12	
Relaxin Signaling	1.74E00	9.03E-02	-2.121	FOS,GDE1,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,JUN,MAPK3,NFKBIA,NT5C,PRKAR1A,SMPDL3A	
Regulation of mRNA stability by proteins that bind AU-rich elements	1.73E00	1.36E-01	-2.449	HSPA1A/HSPA1B,HSPA8,HSPB1,RPS27A,UBC,ZFP36	
Sleep REM Signaling Pathway	1.73E00	9.91E-02	-1.508	ATF4,CFL1,CFL2,CREB3,EIF4E,FOS,GADD45B,MAPK3,Mt1,PRKAR1A,TNFSF12	
GÎ±s Signaling	1.72E00	9.52E-02	-3.000	ADRB2,ATF4,CREB3,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,GPER1,MAPK3,PRKAR1A	
Interconversion of nucleotide di- and triphosphates	1.7E00	1.82E-01	-2.000	CMPK1,GUK1,NME2,TXN	
Endocannabinoid Developing Neuron Pathway	1.7E00	9.45E-02	-3.000	ATF4,CREB3,GNAI2,GNB2,GNG11,GNG5,HRAS,MAPK3,PRKAR1A,RASD1,RHOA,RRAS	
VEGF Signaling	1.67E00	1.01E-01	-1.633	ACTB,ACTG1,BAD,EIF2B4,EIF2S2,HRAS,MAPK3,RASD1,RRAS,YWHAE	
Mitochondrial iron-sulfur cluster biogenesis	1.65E00	2.31E-01	NaN	GLRX5,ISCA1,ISCU	
Advanced glycosylation endproduct receptor signaling	1.65E00	2.31E-01	NaN	CAPZA2,DDOST,MAPK3	
SUMOylation of RNA binding proteins	1.65E00	1.3E-01	-2.449	HNRNPK,PHC2,SEC13,SUMO1,SUMO2,UBE2I	
CDK5 Signaling	1.63E00	9.57E-02	0.333	GNAS,HRAS,MAPK3,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B,PPP2R2D,PRKAR1A,RASD1,RRAS	
Senescence-Associated Secretory Phenotype (SASP)	1.61E00	1.1E-01	-2.828	ANAPC11,CDKN1A,FOS,JUN,MAPK3,RPS27A,UBC,UBE2S	
Endocannabinoid Cancer Inhibition Pathway	1.58E00	8.84E-02	-1.387	ATF3,ATF4,BAD,CDKN1A,CREB3,DDIT3,GNAI2,MAPK3,PRKAB1,PRKAR1A,RHOA,SMPD2,VIM	
PPARÎ±/RXRÎ± Activation	1.58E00	8.25E-02	0.577	ACAA1,AP2A2,GNA11,GNAS,HRAS,HSP90AA1,HSP90AB1,HSP90B1,JUN,MAPK3,NFKBIA,PDIA3,PRKAB1,PRKAR1A,RASD1,RRAS	
Mitochondrial Fatty Acid Beta-Oxidation	1.57E00	1.67E-01	-2.000	ACOT9,ECHS1,ECI1,NDUFAB1	
G alpha (z) signalling events	1.56E00	1.25E-01	-2.449	GNAI2,GNAS,GNB2,GNG11,GNG5,GNGT2	
GÎ±12/13 Signaling	1.56E00	9.02E-02	-2.530	CDH5,HRAS,JUN,MAPK3,MYL12A,MYL12B,MYL6,NFKBIA,RASD1,RHOA,RRAS,TBXA2R	
RAB GEFs exchange GTP for GDP on RABs	1.55E00	1.01E-01	-3.000	CCZ1/CCZ1B,RAB18,RAB5A,RAB9A,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6B,YWHAE	
Caveolar-mediated Endocytosis Signaling	1.55E00	1.07E-01	NaN	ACTB,ACTG1,CAV1,COPE,HLA-A,HLA-E,HLA-G,RAB5A	
Myelination Signaling Pathway	1.55E00	7.34E-02	-2.449	ACVRL1,ARF6,ATF4,Calm1 (includes others),CREB3,EIF4E,EIF4EBP1,FKBP1A,FOS,HRAS,ID2,ILK,JUN,MAPK3,PDGFA,PDGFB,PLP1,PRKAR1A,PSENEN,RASD1,RHEB,RHOA,RRAS,XAF1	
Cardiac Î²-adrenergic Signaling	1.54E00	8.33E-02	0.000	AKAP12,GDE1,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B,PPP2R2D,PRKAR1A,SMPDL3A	
Apoptosis Signaling	1.54E00	9.62E-02	-0.333	BAD,BAX,CYCS,HRAS,LMNA,MAPK3,MCL1,NFKBIA,RASD1,RRAS	
IL-2 Signaling	1.53E00	1.13E-01	-2.000	CSNK2B,FOS,HRAS,JUN,MAPK3,RASD1,RRAS	
TP53 Regulates Transcription of Cell Cycle Genes	1.52E00	1.22E-01	-2.449	BAX,BTG2,CDKN1A,NPM1,PRMT1,RGCC	
GDNF Family Ligand-Receptor Interactions	1.52E00	1.05E-01	-2.449	DOK4,FOS,HRAS,JUN,MAPK3,PDLIM7,RASD1,RRAS	
Macropinocytosis Signaling	1.52E00	1.05E-01	NaN	ARF6,HRAS,PDGFA,PDGFB,RAB5A,RASD1,RHOA,RRAS	
HMGB1 Signaling	1.49E00	8.38E-02	-3.317	Cdc42,FOS,HRAS,IFNGR1,JUN,MAPK3,PLAT,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,TNFSF12	
Signaling by EGFR	1.49E00	1.2E-01	-2.449	AAMP,HBEGF,HRAS,RPS27A,SH3GL1,UBC	
RNA Polymerase I Transcription	1.49E00	1.2E-01	-2.449	MAPK3,MBD3,POLR1D,POLR2E,POLR2F,POLR2K	
Melanoma Signaling	1.49E00	1.2E-01	-0.447	BAD,CDKN1A,HRAS,MAPK3,RASD1,RRAS	
MYC Mediated Apoptosis Signaling	1.49E00	1.2E-01	-1.633	ADRB2,BAX,BBC3,CYCS,MCL1,PRKAR1A	
Corticotropin Releasing Hormone Signaling	1.48E00	8.55E-02	-3.000	ARPC5,ATF4,Calm1 (includes others),CREB3,FOS,GNAI2,GNAS,JUN,JUND,MAPK3,NR4A1,NT5C,PRKAR1A	
ABRA Signaling Pathway	1.47E00	9.78E-02	-1.000	ACTB,ACTG1,CFL1,CFL2,FOS,JUNB,JUND,PPP1CA,RHOA	
Signaling by NOTCH1	1.46E00	1.03E-01	-2.828	CDK8,HES1,HEY1,PSENEN,RPS27A,SNW1,TLE5,UBC	
Neurotrophin/TRK Signaling	1.46E00	1.03E-01	-2.646	ATF4,CREB3,FOS,HRAS,JUN,MAPK3,RASD1,RRAS	
Reelin Signaling in Neurons	1.45E00	8.7E-02	-2.714	APOE,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,CFL1,MAPK3,NDEL1,RHOA	
Telomerase Signaling	1.44E00	9.26E-02	-2.449	CDKN1A,HRAS,HSP90AA1,HSP90AB1,HSP90B1,MAPK3,PPP2R2D,PTGES3,RASD1,RRAS	
GÎ±q Signaling	1.44E00	8.24E-02	-3.162	Calm1 (includes others),Cdc42,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,MAPK3,NFKBIA,RHOA,RHOB,RHOC,RHOG	
Induction of Apoptosis by HIV1	1.43E00	1.08E-01	-1.890	BAX,BBC3,CYCS,NFKBIA,SLC25A3,SLC25A4,SLC25A5	
Hepatic Fibrosis Signaling Pathway	1.42E00	6.86E-02	-3.657	ATF4,Calm1 (includes others),Cdc42,CREB3,CSNK1E,EDN1,FOS,FTH1,FTL,GNAI2,HRAS,JUN,KLF9,MAPK3,MYL12A,MYL12B,MYL6,NFKBIA,PDGFA,PDGFB,PRKAR1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,SDHB,SDHD	
B-WICH complex positively regulates rRNA expression	1.41E00	1.15E-01	-2.449	ACTB,DDX21,POLR1D,POLR2E,POLR2F,POLR2K	
G alpha (12/13) signalling events	1.41E00	1E-01	-2.828	GNB2,GNG11,GNG5,GNGT2,RHOA,RHOB,RHOC,TBXA2R	
Pyroptosis	1.41E00	1.48E-01	-2.000	BAX,CHMP2A,CHMP6,CYCS	
Gluconeogenesis I	1.41E00	1.48E-01	-2.000	ALDOA,GAPDH,MDH2,PGAM1	
SUMOylation of DNA methylation proteins	1.4E00	1.88E-01	NaN	PHC2,SUMO1,UBE2I	
Netrin Signaling	1.38E00	8.09E-02	-3.207	ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,MAPK3,NAPA,PRKAR1A,RHOA,VAMP3,VASP,VTI1B	
Aryl hydrocarbon receptor signalling	1.38E00	2.86E-01	NaN	HSP90AB1,PTGES3	
TYSND1 cleaves peroxisomal proteins	1.38E00	2.86E-01	NaN	ACAA1,SCP2	
Estrogen-Dependent Breast Cancer Signaling	1.35E00	9.76E-02	-2.646	ATF4,CREB3,FOS,HRAS,JUN,MAPK3,RASD1,RRAS	
JAK/STAT Signaling	1.35E00	9.76E-02	-1.134	CDKN1A,FOS,HRAS,JUN,MAPK3,RASD1,RRAS,SOCS2	
BEX2 Signaling Pathway	1.35E00	9.76E-02	0.378	BAD,BBC3,CDKN1A,JUN,LMO2,NFKBIA,PPP2R2D,SWAP70	
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	1.35E00	7.85E-02	-2.138	APOE,Cdc42,CYBA,FOS,IFNGR1,JUN,MAPK3,NFKBIA,PPP1CA,PPP1R11,PPP1R14B,RHOA,RHOB,RHOC,RHOG	
Protein methylation	1.34E00	1.76E-01	NaN	EEF1A1,HSPA8,RPS2	
AMPK Signaling	1.33E00	7.44E-02	-2.333	ACTB,ADRB2,ATF4,CDKN1A,CREB3,EIF4EBP1,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,ORAI1,PFKL,PPP2R2D,PRKAB1,PRKAR1A,RAB11A	
UVA-Induced MAPK Signaling	1.32E00	9.18E-02	-2.000	CYCS,FOS,HRAS,JUN,MAPK3,PDIA3,RASD1,RRAS,SMPD2	
Agrin Interactions at Neuromuscular Junction	1.31E00	1.01E-01	-2.449	ACTB,ACTG1,HRAS,JUN,MAPK3,RASD1,RRAS	
Deadenylation-dependent mRNA decay	1.31E00	1.09E-01	-2.449	EIF4A1,EIF4A3,EIF4E,LSM2,LSM3,LSM5	
Processing of Capped Intronless Pre-mRNA	1.31E00	1.38E-01	-2.000	LSM10,SNRPB,SNRPD3,SNRPF	
Transcriptional regulation of white adipocyte differentiation	1.3E00	9.52E-02	-2.828	CDK8,KLF4,MED10,MED21,MED28,MED7,MED8,MED9	
SUMOylation of chromatin organization proteins	1.28E00	1.07E-01	-2.449	PHC2,SEC13,SUMO1,SUMO2,SUMO3,UBE2I	
ATM Signaling	1.28E00	9E-02	0.000	ATF4,CBX3,CDKN1A,CREB3,GADD45B,GADD45G,JUN,NFKBIA,PPP2R2D	
Gastrin-CREB signalling pathway via PKC and MAPK	1.27E00	1.67E-01	NaN	HBEGF,HRAS,MAPK3	
NFE2L2 regulates pentose phosphate pathway genes	1.27E00	2.5E-01	NaN	NFE2L2,TALDO1	
Activation of kainate receptors upon glutamate binding	1.26E00	1.33E-01	-2.000	GNB2,GNG11,GNG5,GNGT2	
Smooth Muscle Contraction	1.26E00	1.16E-01	-2.236	ALDH2,ANXA2,MYL12A,MYL12B,MYL6	
TNF signaling	1.25E00	1.05E-01	-2.449	RACK1,RPS27A,SMPD2,STUB1,UBC,UBE2D3	
Oxytocin Signaling Pathway	1.25E00	7.09E-02	-4.472	ATF4,Calm1 (includes others),CREB3,FOS,GNA11,GNAI2,GNB2,GNG11,GNG5,HRAS,HSPB1,MAPK3,MYL6,NFE2L2,NT5C,PRKAB1,PRKAR1A,RASD1,RHOA,RRAS	
Neuregulin Signaling	1.24E00	8.55E-02	-1.633	BAD,HBEGF,HRAS,HSP90AA1,HSP90AB1,HSP90B1,MAPK3,RASD1,RPS6,RRAS	
Xenobiotic Metabolism AHR Signaling Pathway	1.23E00	9.2E-02	0.707	ALDH2,GSTM2,HSP90AA1,HSP90AB1,HSP90B1,MGST3,PTGES3,SUMO1	
TP53 Regulates Transcription of Cell Death Genes	1.22E00	1.14E-01	-2.236	BAX,BBC3,BNIP3L,PRELID1,RABGGTB	
Integration of energy metabolism	1.21E00	8.74E-02	-2.236	GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,GNGT2,PRKAR1A,TALDO1	
Amyloid fiber formation	1.21E00	9.59E-02	-2.646	APOE,CST3,ITM2B,PSENEN,RPS27A,TTR,UBC	
Circadian Clock	1.19E00	1.02E-01	-1.000	CREM,CSNK1E,PPP1CA,Ppp1cc,RPS27A,UBC	
SUMOylation of DNA replication proteins	1.19E00	1.11E-01	-2.236	SEC13,SUMO1,SUMO2,SUMO3,UBE2I	
NGF Signaling	1.18E00	8.33E-02	-3.000	ATF4,BAX,CREB3,HRAS,MAPK3,RASD1,RHOA,RHOG,RRAS,SMPD2	
cAMP-mediated signaling	1.18E00	7.2E-02	-2.324	ADRB2,AKAP12,ATF4,Calm1 (includes others),CREB3,CREM,DUSP1,GDE1,GNAI2,GNAS,GPER1,LAMTOR3,MAPK3,PRKAR1A,S1PR1,SMPDL3A,TBXA2R	
Toll Like Receptor 3 (TLR3) Cascade	1.18E00	1.25E-01	-2.000	IRF7,RPS27A,UBC,UBE2D3	
Glutamate binding, activation of AMPA receptors and synaptic plasticity	1.18E00	1.25E-01	-2.000	AP2A2,Ap2b1,AP2M1,AP2S1	
RAR Activation	1.17E00	6.53E-02	-3.402	ACTB,ATF4,Cdc42,CDKN1A,CREB3,CSNK2B,DUSP1,F11R,FOS,GDE1,GNA11,GNGT2,JUN,KLF2,MAPK3,NR2F6,PRKAR1A,PRMT1,PSMC5,RHOA,RHOB,RHOC,RHOG,RPL7A,SMPDL3A,SNW1,SRA1,TNFSF12	
Dopamine-DARPP32 Feedback in cAMP Signaling	1.17E00	7.53E-02	-0.577	ATF4,Calm1 (includes others),CREB3,CREM,CSNK1E,GNAI2,GNAS,PDIA3,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B,PPP2R2D,PRKAR1A	
Endometrial Cancer Signaling	1.16E00	1E-01	-1.342	BAD,HRAS,ILK,MAPK3,RASD1,RRAS	
PCP (Planar Cell Polarity) Pathway	1.16E00	1E-01	-2.449	CTHRC1,JUN,JUNB,JUND,PFN1,RHOA	
Opioid Signalling	1.16E00	8.89E-02	-2.828	GNA11,GNAI2,GNB2,GNG11,GNG5,GNGT2,PPP1CA,PRKAR1A	
Glioblastoma Multiforme Signaling	1.14E00	7.6E-02	-2.714	Cdc42,CDKN1A,HRAS,MAPK3,PDGFA,PDGFB,PDIA3,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
Acute Myeloid Leukemia Signaling	1.14E00	8.79E-02	-1.000	BAD,EIF4EBP1,HRAS,IDH3G,JUP,MAPK3,RASD1,RRAS	
Kinesins	1.13E00	9.84E-02	-2.449	TUBA1A,TUBA1B,TUBA1C,TUBB2A,TUBB2B,TUBB4B	
NOD1/2 Signaling Pathway	1.13E00	7.41E-02	-3.207	FOS,HSP90AA1,HSP90AB1,HSP90B1,HSPA14,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,IRF7,JUN,MAPK3,NFKBIA,TNFSF12	
iNOS Signaling	1.12E00	1.06E-01	-2.000	Calm1 (includes others),FOS,IFNGR1,JUN,NFKBIA	
Role of Tissue Factor in Cancer	1.11E00	7.25E-02	-3.357	CCN1,CFL1,CFL2,EIF4E,FOS,GNA11,HBEGF,HRAS,JUN,MAPK3,PDIA6,PLAUR,PPP2R2D,RASD1,RRAS	
Fcgamma receptor (FCGR) dependent phagocytosis	1.1E00	7.64E-02	-3.464	ACTB,ACTG1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,CFL1,HSP90AA1,HSP90AB1,MAPK3	
WNT/Î²-catenin Signaling	1.1E00	7.47E-02	-0.378	CDH5,CSNK1E,CSNK2B,ILK,JUN,PIN1,PPP2R2D,RPS27A,SOX17,SOX18,SOX7,Ubb,UBC	
Signaling by NOTCH2	1.1E00	1.18E-01	-2.000	HES1,PSENEN,RPS27A,UBC	
Oncogene Induced Senescence	1.1E00	1.18E-01	NaN	ID1,MAPK3,RPS27A,UBC	
SUMOylation of SUMOylation proteins	1.1E00	1.18E-01	-2.000	SEC13,SUMO1,SUMO2,UBE2I	
Cargo concentration in the ER	1.1E00	1.18E-01	-2.000	CNIH1,SAR1B,TMED10,TMED2	
Triglyceride metabolism	1.1E00	1.18E-01	-2.000	CAV1,PLIN3,PPP1CA,Ppp1cc	
Fatty Acid Î²-oxidation I	1.1E00	1.18E-01	-2.000	ACAA1,ECHS1,ECI1,SCP2	
XBP1(S) activates chaperone genes	1.09E00	1.04E-01	-2.236	DNAJB11,LMNA,MYDGF,PDIA6,XBP1	
DNA Damage Bypass	1.09E00	1.04E-01	-2.236	ISG15,RCHY1,RPS27A,UBC,UBE2B	
RHOBTB3 ATPase cycle	1.09E00	2E-01	NaN	PLIN3,RAB9A	
Peroxisomal protein import	1.08E00	9.52E-02	-2.449	ACAA1,ECH1,RPS27A,SCP2,UBC,UBE2D3	
Thrombopoietin Signaling	1.08E00	9.52E-02	-2.236	FOS,HRAS,JUN,MAPK3,RASD1,RRAS	
3-phosphoinositide Degradation	1.07E00	7.25E-02	-3.606	ALPL,DUSP1,DUSP11,DUSP8,MDP1,NT5C,NUDT14,NUDT9,PIP4P1,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B,PTPMT1	
PFKFB4 Signaling Pathway	1.06E00	1.02E-01	-2.000	ATF4,CREB3,GNAS,MAPK3,PRKAR1A	
IL-3 Signaling	1.06E00	8.86E-02	-1.633	BAD,FOS,HRAS,JUN,MAPK3,RASD1,RRAS	
Role of JAK family kinases in IL-6-type Cytokine Signaling	1.06E00	8.86E-02	-2.646	FOS,HSP90AA1,HSP90AB1,HSP90B1,JUNB,MAPK3,MCL1	
RHO GTPases Activate NADPH Oxidases	1.06E00	1.36E-01	NaN	CYBA,MAPK3,PIN1	
Xenobiotic Metabolism PXR Signaling Pathway	1.04E00	7.18E-02	-2.138	ALDH2,ESD,GSTM2,HSP90AA1,HSP90AB1,HSP90B1,MGST3,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B,PRKAR1A,SNW1,SRA1	
Dopamine Receptor Signaling	1.04E00	8.75E-02	NaN	PPP1CA,Ppp1cc,PPP1R11,PPP1R14B,PPP2R2D,PRKAR1A,SPR	
TGF-Î² Signaling	1.03E00	8.33E-02	-1.134	FOS,HRAS,IRF7,JUN,MAPK3,PMEPA1,RASD1,RRAS	
Activation of IRF by Cytosolic Pattern Recognition Receptors	1.03E00	9.23E-02	-0.816	IRF7,ISG15,JUN,NFKBIA,PIN1,PPIB	
ERB2-ERBB3 Signaling	1.03E00	9.23E-02	-1.000	BAD,HRAS,JUN,MAPK3,RASD1,RRAS	
Tumor Microenvironment Pathway	1.03E00	7.26E-02	-1.387	BAD,FOS,HLA-A,HLA-E,HLA-G,HRAS,JUN,MAPK3,MMP15,PDGFA,PDGFB,RASD1,RRAS	
FLT3 Signaling	1.03E00	1.11E-01	-2.000	HRAS,RPS27A,SOCS2,UBC	
Spermine Biosynthesis	1.03E00	5E-01	NaN	AMD1	
Spermidine Biosynthesis I	1.03E00	5E-01	NaN	AMD1	
Xanthine and Xanthosine Salvage	1.03E00	5E-01	NaN	PNP	
Cardiolipin Biosynthesis II	1.03E00	5E-01	NaN	PTPMT1	
IL-6 Signaling	1.02E00	7.75E-02	-2.333	CSNK2B,FOS,HRAS,HSPB1,JUN,MAPK3,MCL1,NFKBIA,RASD1,RRAS	
RHO GTPases activate KTN1	1.02E00	1.82E-01	NaN	RHOA,RHOG	
Alpha-protein kinase 1 signaling pathway	1.02E00	1.82E-01	NaN	RPS27A,UBC	
Signaling by NTRK1 (TRKA)	1.02E00	8.64E-02	-2.646	AP2A2,AP2M1,AP2S1,CLTA,HRAS,MAPK3,RHOA	
RAF-independent MAPK1/3 activation	1.01E00	1.3E-01	NaN	DUSP1,DUSP8,MAPK3	
Transcriptional regulation by RUNX2	1E00	9.8E-02	-2.236	BAX,CDKN1A,HES1,HEY1,MAPK3	
Amyloid Processing	1E00	9.8E-02	NaN	CSNK1E,CSNK2B,MAPK3,PRKAR1A,PSENEN	
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	1E00	9.8E-02	NaN	CDKN1A,PTPMT1,YWHAE,YWHAH,YWHAQ	
Natural Killer Cell Signaling	1E00	7.07E-02	-1.069	CFL1,CFL2,HLA-A,HLA-E,HLA-G,HRAS,HSPA14,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,MAPK3,RASD1,RRAS	
Melanocyte Development and Pigmentation Signaling	9.93E-01	8.16E-02	-2.646	ATF4,CREB3,GNAS,HRAS,MAPK3,PRKAR1A,RASD1,RRAS	
MyD88-independent TLR4 cascade	9.92E-01	1.08E-01	-2.000	IRF7,RPS27A,UBC,UBE2D3	
TWEAK Signaling	9.92E-01	1.08E-01	-1.000	CYCS,NFKBIA,TNFRSF12A,TNFSF12	
Oxytocin in Brain Signaling Pathway	9.87E-01	7.04E-02	-2.673	ATF4,Calm1 (includes others),CREB3,DDIT3,GNA11,GNAI2,GNB2,GNG11,GNG5,HRAS,MAPK3,PRDX6,RASD1,RRAS	
Adrenomedullin signaling pathway	9.87E-01	7.04E-02	-3.464	BAD,BAX,Calm1 (includes others),FOS,GNA11,GNAS,HRAS,MAPK3,NT5C,PDIA3,PRKAR1A,RAMP2,RASD1,RRAS	
Mitotic Roles of Polo-Like Kinase	9.81E-01	8.96E-02	NaN	ANAPC11,HSP90AA1,HSP90AB1,HSP90B1,PPP2R2D,PTTG1	
Methionine Degradation I (to Homocysteine)	9.69E-01	1.25E-01	NaN	MAT2A,MAT2B,PRMT1	
Human Embryonic Stem Cell Pluripotency	9.62E-01	6.97E-02	-3.742	ACVRL1,HRAS,HSP90AA1,HSP90AB1,HSP90B1,ID1,ID2,ID3,KLF2,KLF4,PDGFA,PDGFB,RASD1,RRAS	
Cell Cycle Regulation by BTG Family Proteins	9.6E-01	1.05E-01	NaN	BTG1,BTG2,PPP2R2D,PRMT1	
Notch Signaling	9.6E-01	1.05E-01	NaN	HES1,HEY1,LFNG,PSENEN	
Pulmonary Fibrosis Idiopathic Signaling Pathway	9.53E-01	6.44E-02	-3.441	ACTB,ACTG1,ADAMTS1,BAX,BBC3,CAV1,EDN1,EIF4EBP1,FOS,HES1,HRAS,ILK,JUN,MAPK3,MMP15,PDGFA,PDGFB,RASD1,RHOA,RRAS,VIM	
Vitamin D (calciferol) metabolism	9.52E-01	1.67E-01	NaN	SUMO2,UBE2I	
NAD Signaling Pathway	9.4E-01	7.28E-02	-2.000	HSPD1,LDHA,PDGFB,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,PRKAB1	
SPINK1 General Cancer Pathway	9.36E-01	8.7E-02	-0.447	HRAS,MAPK3,Mt1,Mt2,RASD1,RRAS	
LPS-stimulated MAPK Signaling	9.33E-01	8.24E-02	-2.449	FOS,HRAS,JUN,MAPK3,NFKBIA,RASD1,RRAS	
Incretin synthesis, secretion, and inactivation	9.29E-01	1.2E-01	NaN	SEC11A,SEC11C,SPCS2	
Oxidative Stress Induced Senescence	9.14E-01	8.14E-02	-2.646	FOS,JUN,MAPK3,PHC2,RPS27A,TXN,UBC	
Platelet homeostasis	9.14E-01	8.14E-02	-2.646	GNAS,GNB2,GNG11,GNG5,GNGT2,ORAI1,SRI	
Regulation of lipid metabolism by PPARalpha	9.12E-01	7.56E-02	-2.333	ALAS1,CDK8,MED10,MED21,MED28,MED7,MED8,MED9,NR1H2	
MSP-RON Signaling in Macrophages Pathway	9.12E-01	7.56E-02	-2.333	ATF4,CREB3,FOS,HRAS,IFNGR1,JUN,MAPK3,RASD1,RRAS	
Ribonucleotide Reductase Signaling Pathway	9.01E-01	7.02E-02	-1.732	ACTB,ATF4,BAD,CDKN1A,CREB3,EIF4E,EIF4EBP1,FOS,H3-3A/H3-3B,JUN,MAPK3,YBX1	
Signaling by PTK6	9E-01	9.09E-02	-2.236	HBEGF,HRAS,RHOA,RPS27A,UBC	
Signaling by FGFR3	8.99E-01	1E-01	-2.000	HRAS,MAPK3,RPS27A,UBC	
IL-17A Signaling in Fibroblasts	8.94E-01	8.05E-02	-2.646	ARID5A,FOS,JUN,MAPK3,NFKBIA,P4HA2,SERPINH1	
Trafficking and processing of endosomal TLR	8.93E-01	1.54E-01	NaN	CTSV,HSP90B1	
Assembly of RNA Polymerase I Complex	8.93E-01	1.54E-01	NaN	POLR1D,POLR2F	
Guanosine Nucleotides Degradation III	8.93E-01	1.54E-01	NaN	NT5C,PNP	
Chronic Myeloid Leukemia Signaling	8.92E-01	6.47E-02	-2.357	BAD,Calm1 (includes others),CDKN1A,FOS,HES1,HRAS,HSP90AA1,HSP90AB1,HSP90B1,JUN,KLF4,MAPK3,MCL1,PDIA3,PRKAB1,RAN,RASD1,RRAS	
WNT ligand biogenesis and trafficking	8.91E-01	1.15E-01	NaN	SNX3,TMED5,VPS29	
IL-17A Signaling in Gastric Cells	8.91E-01	1.15E-01	NaN	FOS,JUN,MAPK3	
Cysteine Biosynthesis III (mammalia)	8.91E-01	1.15E-01	NaN	MAT2A,MAT2B,PRMT1	
Macrophage Alternative Activation Signaling Pathway	8.81E-01	6.84E-02	-1.941	ATF4,CREB3,DUSP1,EIF4EBP1,FOS,H3-3A/H3-3B,IL10RB,JUN,KLF4,MAPK3,NFKBIA,NR1H2,TSC22D3	
NLR signaling pathways	8.76E-01	8.93E-02	-2.236	AAMP,HSP90AB1,RPS27A,TXN,UBC	
EGF Signaling	8.76E-01	8.93E-02	-2.236	CSNK2B,FOS,HRAS,JUN,MAPK3	
Transport of vitamins, nucleosides, and related molecules	8.7E-01	9.76E-02	-2.000	ARL2BP,PDZD11,SLC25A4,SLC25A5	
Signaling by FGFR4	8.7E-01	9.76E-02	-2.000	HRAS,MAPK3,RPS27A,UBC	
MTF1 activates gene expression	8.6E-01	3.33E-01	NaN	CSRP1	
NFE2L2 regulating TCA cycle genes	8.6E-01	3.33E-01	NaN	NFE2L2	
Regulation of NFE2L2 gene expression	8.6E-01	3.33E-01	NaN	NFE2L2	
Guanine and Guanosine Salvage I	8.6E-01	3.33E-01	NaN	PNP	
Glutathione Biosynthesis	8.6E-01	3.33E-01	NaN	GCLM	
Tetrahydrobiopterin Biosynthesis I	8.6E-01	3.33E-01	NaN	SPR	
Hypusine Biosynthesis	8.6E-01	3.33E-01	NaN	EIF5A	
Adenine and Adenosine Salvage I	8.6E-01	3.33E-01	NaN	PNP	
Tetrahydrobiopterin Biosynthesis II	8.6E-01	3.33E-01	NaN	SPR	
N-acetylglucosamine Degradation I	8.6E-01	3.33E-01	NaN	GNPDA2	
CD27 Signaling in Lymphocytes	8.53E-01	8.77E-02	NaN	CYCS,FOS,JUN,NFKBIA,TRAF5	
April Mediated Signaling	8.43E-01	9.52E-02	-1.000	FOS,JUN,NFKBIA,TRAF5	
Pancreatic Secretion Signaling Pathway	8.4E-01	6.48E-02	-3.000	ARHGDIA,CA2,EIF4EBP1,GNAS,MAPK3,NAPA,ORAI1,PDIA3,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B,PRKAR1A,RHOA,VAMP3,VTI1B	
Acyl-CoA Hydrolysis	8.39E-01	1.43E-01	NaN	ACOT9,PPT1	
Urate Biosynthesis/Inosine 5'-phosphate Degradation	8.39E-01	1.43E-01	NaN	NT5C,PNP	
Post-translational protein phosphorylation	8.35E-01	7.48E-02	-2.828	APOE,CCN1,CST3,HSP90B1,PDIA6,PRSS23,SHISA5,VWA1	
Cancer Drug Resistance by Drug Efflux	8.3E-01	8.62E-02	-2.236	HRAS,MAPK3,RASD1,RRAS,YBX1	
Factors involved in megakaryocyte development and platelet production	8.22E-01	7.69E-02	-2.646	ACTB,CAPZA2,EHD2,HMG20B,MAFF,PRKAR1A,RAB5A	
BMP signaling pathway	8.22E-01	7.69E-02	-2.236	ACVRL1,HRAS,JUN,MAPK3,PRKAR1A,RASD1,RRAS	
Glioma Signaling	8.2E-01	7.2E-02	-2.449	Calm1 (includes others),CDKN1A,HRAS,IDH3G,MAPK3,PDGFA,PDGFB,RASD1,RRAS	
B Cell Activating Factor Signaling	8.16E-01	9.3E-02	NaN	FOS,JUN,NFKBIA,TRAF5	
Oncostatin M Signaling	8.16E-01	9.3E-02	NaN	HRAS,MAPK3,RASD1,RRAS	
GPCR-Mediated Integration of Enteroendocrine Signaling Exemplified by an L Cell	8.12E-01	8E-02	0.000	ADRB2,GNA11,GNAI2,GNAS,PDIA3,PRKAR1A	
DNA Double Strand Break Response	8.08E-01	8.47E-02	-2.236	RPS27A,SUMO1,UBC,UBE2I,UBXN1	
Signaling by Activin	7.91E-01	1.33E-01	NaN	DRAP1,MAPK3	
Regulation of cholesterol biosynthesis by SREBP (SREBF)	7.91E-01	1.33E-01	NaN	RAN,SAR1B	
MIF Regulation of Innate Immunity	7.91E-01	9.09E-02	-2.000	FOS,JUN,MAPK3,NFKBIA	
Interleukin-4 and Interleukin-13 signaling	7.88E-01	7.27E-02	-2.828	CDKN1A,FOS,HSP90AA1,HSPA8,JUNB,MCL1,S1PR1,VIM	
Kinetochore Metaphase Signaling Pathway	7.88E-01	7.27E-02	0.707	ANAPC11,ARPP19,BUB3,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B,PTTG1	
ERBB Signaling	7.88E-01	7.53E-02	-2.449	FOS,HBEGF,HRAS,JUN,MAPK3,RASD1,RRAS	
D-myo-inositol-5-phosphate Metabolism	7.87E-01	6.57E-02	-3.464	ALPL,DUSP1,DUSP11,DUSP8,MDP1,NT5C,NUDT14,NUDT9,PIP4P1,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B	
GABA receptor activation	7.87E-01	8.33E-02	-2.236	GNAI2,GNB2,GNG11,GNG5,GNGT2	
Interferon gamma signaling	7.71E-01	7.45E-02	-2.646	HLA-A,HLA-E,HLA-G,IFNGR1,IRF7,SUMO1,TRIM8	
D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis	7.65E-01	6.59E-02	-3.317	ALPL,DUSP1,DUSP11,DUSP8,MDP1,NT5C,NUDT14,NUDT9,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B	
D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis	7.65E-01	6.59E-02	-3.317	ALPL,DUSP1,DUSP11,DUSP8,MDP1,NT5C,NUDT14,NUDT9,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B	
Regulation of TP53 Activity through Acetylation	7.57E-01	1E-01	NaN	MBD3,PIN1,PIP4P1	
VDR/RXR Activation	7.57E-01	7.69E-02	NaN	CDKN1A,GTF2B,HES1,KLF4,PDGFA,PSMC5	
Toll-like Receptor Signaling	7.57E-01	7.69E-02	NaN	FOS,JUN,NFKBIA,RPS27A,Ubb,UBC	
Prolactin Signaling	7.55E-01	7.37E-02	-1.633	FOS,HRAS,JUN,MAPK3,RASD1,RRAS,SOCS2	
ID1 Signaling Pathway	7.54E-01	6.47E-02	-1.941	ACVRL1,ATF3,BAX,CAV1,CDKN1A,HRAS,ID1,MAPK3,PARK7,RASD1,RHOC,RRAS,VIM	
Ion channel transport	7.54E-01	6.56E-02	-3.162	ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,PDZD11,RPS27A,SGK1,SRI,TSC22D3,UBC	
Orexin Signaling Pathway	7.48E-01	6.3E-02	-3.873	ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,Calm1 (includes others),GNAS,GNB2,GNG11,GNG5,MAPK3,PDIA3,PRKAB1,PRKAR1A	
FOXO-mediated transcription of cell death genes	7.46E-01	1.25E-01	NaN	BBC3,DDIT3	
Adenosine Nucleotides Degradation II	7.46E-01	1.25E-01	NaN	NT5C,PNP	
Parkinson's Signaling	7.46E-01	1.25E-01	NaN	CYCS,PARK7	
Spermine and Spermidine Degradation I	7.45E-01	2.5E-01	NaN	SAT1	
Phenylethylamine Degradation I	7.45E-01	2.5E-01	NaN	ALDH2	
Glutathione Redox Reactions II	7.45E-01	2.5E-01	NaN	PDIA3	
D-glucuronate Degradation I	7.45E-01	2.5E-01	NaN	AKR1A1	
Rapoport-Luebering Glycolytic Shunt	7.45E-01	2.5E-01	NaN	PGAM1	
N-acetylglucosamine Degradation II	7.45E-01	2.5E-01	NaN	GNPDA2	
Fatty Acid Î²-oxidation III (Unsaturated, Odd Number)	7.45E-01	2.5E-01	NaN	ECI1	
Cytosolic sensors of pathogen-associated DNA	7.42E-01	8.7E-02	-2.000	IRF7,NFKBIA,RPS27A,UBC	
tRNA Splicing	7.42E-01	8.7E-02	-2.000	GDE1,SMPDL3A,TSEN15,TSEN34	
Xenobiotic Metabolism Signaling	7.41E-01	6.12E-02	NaN	ALDH2,ESD,FTL,GSTM2,HRAS,HSP90AA1,HSP90AB1,HSP90B1,MAPK3,MGST3,NFE2L2,PPP2R2D,PTGES3,RASD1,RRAS,SNW1,SRA1,SUMO1	
Death Receptor Signaling	7.39E-01	7.29E-02	-1.134	ACTB,ACTG1,CYCS,HSPB1,LMNA,NFKBIA,TNFSF12	
Thyroid Cancer Signaling	7.39E-01	7.59E-02	-2.449	FOS,HRAS,JUN,MAPK3,RASD1,RRAS	
MyD88 dependent cascade initiated on endosome	7.27E-01	9.68E-02	NaN	IRF7,RPS27A,UBC	
Glucose metabolism	7.22E-01	7.5E-02	-2.449	ALDOA,GNPDA2,MDH2,PFKL,PKM,SEC13	
Dilated Cardiomyopathy Signaling Pathway	7.21E-01	6.67E-02	-0.707	ACTB,ACTG1,BAD,BAX,GNAS,ILK,LMNA,MAPK3,MYL6,PRKAR1A	
Cellular Effects of Sildenafil (Viagra)	7.21E-01	6.67E-02	NaN	ACTB,ACTG1,Calm1 (includes others),GNAS,MYL12A,MYL12B,MYL6,PABPC4,PDIA3,PRKAR1A	
p53 Signaling	7.09E-01	7.14E-02	-1.000	BAX,BBC3,CDKN1A,GADD45B,GADD45G,JUN,ST13	
DNA Methylation and Transcriptional Repression Signaling	7.09E-01	7.14E-02	-2.449	CDK8,CDK9,GADD45B,GADD45G,MBD3,SAP18,TCF15	
Signaling by NTRK3 (TRKC)	7.05E-01	1.18E-01	NaN	BAX,HRAS	
RAN Signaling	7.05E-01	1.18E-01	NaN	RAN,RANBP1	
TNFR2 Signaling	6.99E-01	9.38E-02	NaN	FOS,JUN,NFKBIA	
Apelin Cardiomyocyte Signaling Pathway	6.94E-01	7.07E-02	-2.646	GNA11,GNAI2,MAPK3,MYL12A,MYL12B,MYL6,PDIA3	
RAB geranylgeranylation	6.88E-01	7.69E-02	-2.236	RAB11A,RAB18,RAB5A,RAB9A,RABGGTB	
STAT3 Pathway	6.85E-01	6.67E-02	-1.134	CDKN1A,HRAS,IL10RB,MAPK3,NDUFA13,PDGFB,RASD1,RRAS,SOCS2	
SNARE Signaling Pathway	6.73E-01	6.62E-02	-3.000	Calm1 (includes others),HSPA8,MYL6,NAPA,PRKAR1A,RAB11A,SGTA,VAMP3,VTI1B	
MAPK targets/ Nuclear events mediated by MAP kinases	6.73E-01	9.09E-02	NaN	FOS,JUN,MAPK3	
Degradation of the extracellular matrix	6.7E-01	7.58E-02	-2.236	ADAMTS1,BSG,CTSV,HTRA1,MMP15	
DHCR24 Signaling Pathway	6.61E-01	6.57E-02	-3.000	APOE,HRAS,NR1H2,PDGFA,PDGFB,PLTP,RASD1,RRAS,TTR	
Formation of xylulose-5-phosphate	6.59E-01	2E-01	NaN	AKR1A1	
Arsenate Detoxification I (Glutaredoxin)	6.59E-01	2E-01	NaN	PNP	
Creatine-phosphate Biosynthesis	6.59E-01	2E-01	NaN	CKB	
Tetrapyrrole Biosynthesis II	6.59E-01	2E-01	NaN	ALAS1	
Myo-inositol Biosynthesis	6.59E-01	2E-01	NaN	ISYNA1	
Trans, trans-farnesyl Diphosphate Biosynthesis	6.59E-01	2E-01	NaN	FDPS	
Regulation of the Epithelial Mesenchymal Transition by Growth Factors Pathway	6.58E-01	6.25E-02	-2.309	FOS,HRAS,ID2,JUN,MAPK3,PDGFA,PDGFB,RASD1,RHOA,RRAS,TNFSF12,VIM	
Role of MAPK Signaling in the Pathogenesis of Influenza	6.57E-01	7.14E-02	NaN	BAX,HRAS,MAPK3,PRDX6,RASD1,RRAS	
PEDF Signaling	6.57E-01	7.14E-02	-1.000	HRAS,MAPK3,NFKBIA,RASD1,RHOA,RRAS	
Signaling by FGFR1	6.55E-01	8E-02	-2.000	HRAS,MAPK3,RPS27A,UBC	
CD40 Signaling	6.53E-01	7.46E-02	-1.342	FOS,JUN,MAPK3,NFKBIA,TRAF5	
Leukocyte Extravasation Signaling	6.48E-01	6.22E-02	-2.111	ACTB,ACTG1,CDH5,CLDN5,CYBA,F11R,GNAI2,MMP15,MYL6,RDX,RHOA,VASP	
4-1BB Signaling in T Lymphocytes	6.47E-01	8.82E-02	NaN	JUN,MAPK3,NFKBIA	
Endothelin-1 Signaling	6.38E-01	6.19E-02	-3.162	EDN1,FOS,GNA11,GNAI2,GNAS,HRAS,JUN,MAPK3,PDIA3,PRDX6,RASD1,RRAS	
ERBB4 Signaling	6.36E-01	7.35E-02	NaN	HRAS,MAPK3,PSENEN,RASD1,RRAS	
TNFR1 Signaling	6.35E-01	7.84E-02	-2.000	CYCS,FOS,JUN,NFKBIA	
Regulation of TP53 Activity through Methylation	6.32E-01	1.05E-01	NaN	RPS27A,UBC	
Metabolism of cofactors	6.32E-01	1.05E-01	NaN	HSP90AA1,SPR	
FOXO-mediated transcription	6.32E-01	1.05E-01	NaN	TXN,YWHAQ	
Purine Nucleotides Degradation II (Aerobic)	6.32E-01	1.05E-01	NaN	NT5C,PNP	
Role of Osteoclasts in Rheumatoid Arthritis Signaling Pathway	6.27E-01	5.84E-02	-3.771	ATF4,BAD,Calm1 (includes others),Cdc42,CREB3,FOS,HRAS,JUN,MAPK3,MMP15,NFKBIA,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,TRAF5	
Mouse Embryonic Stem Cell Pluripotency	6.24E-01	6.73E-02	-2.449	HRAS,ID1,ID2,ID3,MAPK3,RASD1,RRAS	
GPVI-mediated activation cascade	6.23E-01	8.57E-02	NaN	RHOA,RHOB,RHOG	
Ethanol Degradation II	6.23E-01	8.57E-02	NaN	ADH5,AKR1A1,ALDH2	
Sensory processing of sound by inner hair cells of the cochlea	6.19E-01	7.25E-02	-2.236	ACTB,ACTG1,CAPZA2,RDX,TWF2	
Apoptotic execution phase	6.15E-01	7.69E-02	-2.000	BCAP31,FNTA,LMNA,VIM	
GM-CSF Signaling	6.03E-01	7.14E-02	-2.000	HRAS,MAPK3,RACK1,RASD1,RRAS	
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by IGFBPs	6E-01	6.45E-02	-2.828	APOE,CCN1,CST3,HSP90B1,PDIA6,PRSS23,SHISA5,VWA1	
Xenobiotic Metabolism General Signaling Pathway	5.93E-01	6.29E-02	-2.828	FTL,GSTM2,HRAS,MAPK3,MGST3,NFE2L2,NR1H2,RASD1,RRAS	
Pyruvate Fermentation to Lactate	5.9E-01	1.67E-01	NaN	LDHA	
Pentose Phosphate Pathway (Non-oxidative Branch)	5.9E-01	1.67E-01	NaN	TALDO1	
Paxillin Signaling	5.85E-01	6.54E-02	-2.449	ACTB,ACTG1,ARF1,ARF6,HRAS,RASD1,RRAS	
Adrenergic Receptor Signaling Pathway (Enhanced)	5.82E-01	6E-02	-2.887	ADRB2,ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,GNAI2,GNAS,PDIA3,PRKAR1A,TNFSF12	
Noradrenaline and Adrenaline Degradation	5.77E-01	8.11E-02	NaN	ADH5,AKR1A1,ALDH2	
ISGylation Signaling Pathway	5.73E-01	6.48E-02	-1.134	CHMP5,EIF4E2,IL10RB,IRF7,ISG15,RTN4,SQSTM1	
Melatonin Signaling	5.72E-01	6.94E-02	-2.236	Calm1 (includes others),GNAI2,MAPK3,PDIA3,PRKAR1A	
RHO GTPases activate PAKs	5.69E-01	9.52E-02	NaN	MYL12B,MYL6	
Sensory processing of sound by outer hair cells of the cochlea	5.61E-01	7.27E-02	-2.000	ACTB,ACTG1,RDX,TWF2	
Lymphotoxin Î² Receptor Signaling	5.61E-01	7.27E-02	-1.000	CYCS,MAPK3,NFKBIA,TRAF5	
RANK Signaling in Osteoclasts	5.58E-01	6.59E-02	-2.236	Calm1 (includes others),FOS,JUN,MAPK3,NFKBIA,TRAF5	
SUMOylation of ubiquitinylation proteins	5.56E-01	7.89E-02	NaN	SEC13,SUMO1,UBE2I	
Glutathione-mediated Detoxification	5.56E-01	7.89E-02	NaN	Gsta4,GSTM2,MGST3	
Senescence Pathway	5.53E-01	5.69E-02	-2.324	ANAPC11,ATF3,Calm1 (includes others),CDKN1A,EIF4E,EIF4EBP1,GADD45B,GADD45G,HRAS,JUN,MAPK3,PDHB,PPP1CA,PPP2R2D,RASD1,RRAS,SQSTM1	
Acute Phase Response Signaling	5.48E-01	5.95E-02	-1.897	FOS,FTL,HNRNPK,HRAS,JUN,MAPK3,NFKBIA,RASD1,RRAS,SOCS2,TTR	
CSDE1 Signaling Pathway	5.44E-01	7.14E-02	-2.000	FOS,PABPC4,RPL9,VIM	
Folate Signaling Pathway	5.44E-01	7.14E-02	-2.000	CDKN1A,KLF4,MAPK3,MAT2A	
Putrescine Degradation III	5.41E-01	9.09E-02	NaN	ALDH2,SAT1	
Regulation of TP53 Expression and Degradation	5.36E-01	7.69E-02	NaN	RPS27A,SGK1,UBC	
Superpathway of Methionine Degradation	5.36E-01	7.69E-02	NaN	MAT2A,MAT2B,PRMT1	
Erythrocytes take up oxygen and release carbon dioxide	5.33E-01	1.43E-01	NaN	CA2	
Pentose phosphate pathway	5.33E-01	1.43E-01	NaN	TALDO1	
Ceramide Biosynthesis	5.33E-01	1.43E-01	NaN	SPTSSA	
Thioredoxin Pathway	5.33E-01	1.43E-01	NaN	TXN	
Acetyl-CoA Biosynthesis I (Pyruvate Dehydrogenase Complex)	5.33E-01	1.43E-01	NaN	PDHB	
Adenine and Adenosine Salvage III	5.33E-01	1.43E-01	NaN	PNP	
Aspartate Degradation II	5.33E-01	1.43E-01	NaN	MDH2	
Endocannabinoid Neuronal Synapse Pathway	5.31E-01	6.04E-02	-1.414	GNA11,GNAI2,GNB2,GNG11,GNG5,MAPK3,NDUFS2,PDIA3,PRKAR1A	
IL-17 Signaling	5.3E-01	5.88E-02	-3.317	FOS,HRAS,HSP90AA1,HSP90AB1,HSP90B1,JUN,MAPK3,RASD1,RRAS,TNFSF12,TRAF5	
CNTF Signaling	5.28E-01	7.02E-02	NaN	HRAS,MAPK3,RASD1,RRAS	
Binding and Uptake of Ligands by Scavenger Receptors	5.26E-01	6.25E-02	-2.646	APOE,FTH1,FTL,HSP90AA1,HSP90B1,HSPH1,SPARC	
Semaphorin Neuronal Repulsive Signaling Pathway	5.21E-01	6E-02	-0.333	CFL1,CFL2,MYL12A,MYL12B,MYL6,PLXND1,PRKAR1A,RHOA,RRAS	
Non-Small Cell Lung Cancer Signaling	5.2E-01	6.38E-02	-1.342	BAD,HRAS,MAPK3,RASD1,RASSF1,RRAS	
Pyrimidine Ribonucleotides Interconversion	5.16E-01	7.5E-02	NaN	CMPK1,NME2,PGP	
Angiopoietin Signaling	5.15E-01	6.58E-02	0.000	BAD,HRAS,NFKBIA,RASD1,RRAS	
3-phosphoinositide Biosynthesis	5.14E-01	5.77E-02	-3.317	ALPL,DUSP1,DUSP11,DUSP8,MDP1,NT5C,NUDT14,NUDT9,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B	
Signaling by NODAL	5.14E-01	8.7E-02	NaN	DRAP1,MAPK3	
Role of Lipids/Lipid Rafts in the Pathogenesis of Influenza	5.14E-01	8.7E-02	NaN	FDPS,RSAD2	
Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I	5.14E-01	8.7E-02	NaN	CMPK1,NME2	
Vitamin-C Transport	5.14E-01	8.7E-02	NaN	LRRC8A,TXN	
Signaling by PDGF	5.12E-01	6.9E-02	-2.000	HRAS,PDGFA,PDGFB,PLAT	
PTEN Signaling	5.12E-01	5.96E-02	1.414	BAD,CDKN1A,CSNK2B,HRAS,ILK,MAPK3,RASD1,RRAS,YWHAH	
Gamma carboxylation, hypusine formation and arylsulfatase activation	4.97E-01	7.32E-02	NaN	DPH3,EIF5A,TPST2	
Class B/2 (Secretin family receptors)	4.96E-01	6.25E-02	-2.449	GNAS,GNB2,GNG11,GNG5,GNGT2,RAMP2	
Docosahexaenoic Acid (DHA) Signaling	4.89E-01	5.6E-02	-1.069	ATF4,BAD,BAX,CREB3,CYCS,GNAS,MAPK3,NFE2L2,PDGFB,PDIA3,PRDX6,PRKAB1,PRKAR1A,PSENEN	
Sulfur amino acid metabolism	4.89E-01	8.33E-02	NaN	ETHE1,TXN2	
Glycogen metabolism	4.89E-01	8.33E-02	NaN	RPS27A,UBC	
Growth hormone receptor signaling	4.89E-01	8.33E-02	NaN	MAPK3,SOCS2	
IL-22 Signaling	4.89E-01	8.33E-02	NaN	IL10RB,MAPK3	
Tumoricidal Function of Hepatic Natural Killer Cells	4.89E-01	8.33E-02	NaN	BAX,CYCS	
NF-ÎºB Activation by Viruses	4.88E-01	6.41E-02	-2.000	HRAS,MAPK3,NFKBIA,RASD1,RRAS	
IL-7 Signaling Pathway	4.88E-01	6.41E-02	0.447	BAD,BAX,JUN,MAPK3,MCL1	
Purine Ribonucleosides Degradation to Ribose-1-phosphate	4.85E-01	1.25E-01	NaN	PNP	
Sphingomyelin Metabolism	4.85E-01	1.25E-01	NaN	SMPD2	
Bladder Cancer Signaling	4.83E-01	6.03E-02	NaN	CDKN1A,HRAS,MAPK3,MMP15,RASD1,RASSF1,RRAS	
Signaling by MET	4.75E-01	6.33E-02	-2.236	ARF6,HRAS,RPS27A,SH3GL1,UBC	
Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza	4.75E-01	6.33E-02	-1.000	BAX,JUN,MAPK3,NFKBIA,PRDX6	
Xenobiotic Metabolism CAR Signaling Pathway	4.72E-01	5.67E-02	-2.530	ALDH2,GSTM2,HSP90AA1,HSP90AB1,HSP90B1,MAPK3,MGST3,PPP2R2D,RACK1,SNW1,SRA1	
MyD88 cascade initiated on plasma membrane	4.66E-01	8E-02	NaN	RPS27A,UBC	
GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells	4.63E-01	5.93E-02	-1.890	GNA11,GNAI2,GNAS,GNG11,GNG5,PDIA3,PRKAR1A	
Pyrimidine Ribonucleotides De Novo Biosynthesis	4.62E-01	6.98E-02	NaN	CMPK1,NME2,PGP	
Superpathway of Inositol Phosphate Compounds	4.51E-01	5.51E-02	-3.464	ALPL,DUSP1,DUSP11,DUSP8,MDP1,NT5C,NUDT14,NUDT9,PIP4P1,PPP1CA,Ppp1cc,PPP1R11,PPP1R14B	
TAK1-dependent IKK and NF-kappa-B activation	4.46E-01	6.82E-02	NaN	NFKBIA,RPS27A,UBC	
Sucrose Degradation V (Mammalian)	4.44E-01	1.11E-01	NaN	ALDOA	
Heme Biosynthesis II	4.44E-01	1.11E-01	NaN	ALAS1	
Nitric Oxide Signaling in the Cardiovascular System	4.43E-01	5.83E-02	-1.890	Calm1 (includes others),CAV1,HSP90AA1,HSP90AB1,HSP90B1,MAPK3,PRKAR1A	
p38 MAPK Signaling	4.43E-01	5.83E-02	-1.890	ATF4,CREB3,DDIT3,DUSP1,H3-3A/H3-3B,HMGN1,HSPB1	
Synaptic Long Term Depression	4.42E-01	5.56E-02	-2.646	GNA11,GNAI2,GNAS,HRAS,MAPK3,NT5C,PDIA3,PPP2R2D,PRDX6,RASD1,RRAS	
PIP3 activates AKT signaling	4.37E-01	5.71E-02	-2.828	BAD,CDKN1A,HBEGF,MAPK3,NR4A1,PDGFA,PDGFB,RHOG	
Renin-Angiotensin Signaling	4.34E-01	5.79E-02	-2.449	FOS,HRAS,JUN,MAPK3,PRKAR1A,RASD1,RRAS	
Arachidonic acid metabolism	4.3E-01	6.67E-02	NaN	GPX1,GPX4,PON2	
Neuroprotective Role of THOP1 in Alzheimer's Disease	4.24E-01	5.74E-02	NaN	HLA-A,HLA-E,HLA-G,HTRA1,PRKAR1A,PRSS23,YWHAE	
Tryptophan Degradation X (Mammalian, via Tryptamine)	4.23E-01	7.41E-02	NaN	AKR1A1,ALDH2	
Mitotic Prophase	4.2E-01	5.83E-02	-2.449	ARPP19,EMD,LMNA,MAPK3,PPP2R2D,SEC13	
VEGF Family Ligand-Receptor Interactions	4.17E-01	5.95E-02	-2.000	FOS,HRAS,MAPK3,RASD1,RRAS	
Apelin Pancreas Signaling Pathway	4.15E-01	6.52E-02	NaN	DDIT3,PRKAB1,PRKAR1A	
Neurotransmitter clearance	4.08E-01	1E-01	NaN	ALDH2	
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	4.08E-01	1E-01	NaN	TSC22D1	
Caspase activation via Dependence Receptors in the absence of ligand	4.08E-01	1E-01	NaN	DAPK3	
Prostanoid Biosynthesis	4.08E-01	1E-01	NaN	PTGES3	
Calcium Transport I	4.08E-01	1E-01	NaN	ANXA5	
Glyoxylate metabolism and glycine degradation	4.03E-01	7.14E-02	NaN	NDUFAB1,PDHB	
Glutamate Receptor Signaling	4.02E-01	6.06E-02	NaN	Calm1 (includes others),GNB2,GNG11,GNG5	
Role of IL-17F in Allergic Inflammatory Airway Diseases	4E-01	6.38E-02	NaN	ATF4,CREB3,MAPK3	
Ephrin A Signaling	4E-01	6.38E-02	NaN	CFL1,CFL2,RHOA	
Role of NFAT in Cardiac Hypertrophy	3.99E-01	5.36E-02	-2.530	Calm1 (includes others),GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,PDIA3,PRKAR1A,RASD1,RRAS	
G alpha (s) signalling events	3.95E-01	5.52E-02	-2.828	ADRB2,GNAI2,GNAS,GNB2,GNG11,GNG5,GNGT2,RAMP2	
Phase II - Conjugation of compounds	3.9E-01	5.97E-02	-2.000	ESD,MAT2A,MAT2B,TRMT112	
Collagen biosynthesis and modifying enzymes	3.9E-01	5.97E-02	-2.000	COL14A1,P4HA2,PPIB,SERPINH1	
NAFLD Signaling Pathway	3.86E-01	5.31E-02	-2.309	ATF4,BAX,BBC3,DDIT3,FOS,JUN,NFE2L2,PPP2R2D,PRKAB1,SOCS2,TNFSF12,XBP1	
Sphingolipid metabolism	3.85E-01	5.75E-02	-2.236	CERS2,GLTP,SMPD2,SPTSSA,VAPA	
FXR/RXR Activation	3.79E-01	5.35E-02	-1.897	APOE,DDIT3,GCLM,GSTM2,MGST3,Mt1,NFE2L2,PLTP,PRKAB1,TNFSF12	
Erythrocytes take up carbon dioxide and release oxygen	3.77E-01	9.09E-02	NaN	CA2	
Oleate Biosynthesis II (Animals)	3.77E-01	9.09E-02	NaN	CYB5A	
Pentose Phosphate Pathway	3.77E-01	9.09E-02	NaN	TALDO1	
Dolichyl-diphosphooligosaccharide Biosynthesis	3.77E-01	9.09E-02	NaN	DPM3	
Role of JAK1 and JAK3 in Î³c Cytokine Signaling	3.67E-01	5.8E-02	NaN	HRAS,MAPK3,RASD1,RRAS	
Cell Cycle: G1/S Checkpoint Regulation	3.67E-01	5.8E-02	-2.000	CDKN1A,PAK1IP1,RPL11,RPL5	
NR1H2 and NR1H3-mediated signaling	3.59E-01	6E-02	NaN	APOE,NR1H2,PLTP	
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis	3.53E-01	5.11E-02	NaN	ATF4,Calm1 (includes others),CEBPG,CREB3,CSNK1E,FOS,HRAS,JUN,MAPK3,NFKBIA,PDGFA,PDGFB,PDIA3,RASD1,RHOA,RRAS,TRAF5	
Wound Healing Signaling Pathway	3.52E-01	5.16E-02	-2.496	FOS,HBEGF,HRAS,IFNGR1,JUN,MAPK3,NFKBIA,PDGFA,PDGFB,RASD1,RRAS,TNFSF12,VIM	
Asparagine N-linked glycosylation	3.51E-01	6.45E-02	NaN	NUDT14,PDIA3	
Signaling by CSF1 (M-CSF) in myeloid cells	3.51E-01	6.45E-02	NaN	RPS27A,UBC	
Methylglyoxal Degradation III	3.51E-01	6.45E-02	NaN	AKR1A1,DHRS7	
Reversible hydration of carbon dioxide	3.49E-01	8.33E-02	NaN	CA2	
Î³-glutamyl Cycle	3.49E-01	8.33E-02	NaN	GCLM	
Crosstalk between Dendritic Cells and Natural Killer Cells	3.46E-01	5.49E-02	NaN	ACTB,ACTG1,HLA-A,HLA-E,HLA-G	
HGF Signaling	3.41E-01	5.3E-02	-1.633	CDKN1A,FOS,HRAS,JUN,MAPK3,RASD1,RRAS	
Acetylcholine Receptor Signaling Pathway	3.34E-01	5.15E-02	-2.530	ATF4,Calm1 (includes others),CREB3,GNA11,GNAI2,MAPK3,NFE2L2,PDIA3,PRKAR1A,PSENEN	
Regulation of TP53 Activity through Phosphorylation	3.29E-01	5.38E-02	-2.236	CSNK2B,PIN1,PRKAB1,RPS27A,UBC	
Cytosolic iron-sulfur cluster assembly	3.23E-01	7.69E-02	NaN	CIAO2B	
UDP-N-acetyl-D-galactosamine Biosynthesis II	3.23E-01	7.69E-02	NaN	GNPDA2	
Activation of Matrix Metalloproteinases	3.2E-01	6.06E-02	NaN	CTSV,MMP15	
Erythropoietin Signaling Pathway	3.19E-01	5.11E-02	-1.000	BAD,FOS,HRAS,JUN,MAPK3,NFKBIA,RASD1,RRAS,TNFSF12	
IL-13 Signaling Pathway	3.08E-01	5.17E-02	-2.449	DUSP1,HBEGF,JUN,MAPK3,PDGFA,RHOA	
Antimicrobial peptides	3.06E-01	5.88E-02	NaN	ATOX1,PDZD11	
Pulmonary Healing Signaling Pathway	3.05E-01	5.03E-02	-2.530	CFL1,CFL2,HBEGF,HRAS,MAPK3,MMP15,NFKBIA,PRKAB1,RASD1,RRAS	
Aspirin ADME	3.01E-01	7.14E-02	NaN	BSG	
Leukotriene Biosynthesis	3.01E-01	7.14E-02	NaN	MGST3	
Phenylalanine Degradation IV (Mammalian, via Side Chain)	3.01E-01	7.14E-02	NaN	ALDH2	
Pre-NOTCH Expression and Processing	2.98E-01	5.26E-02	-2.000	JUN,LFNG,SNW1,TMED2	
Salvage Pathways of Pyrimidine Ribonucleotides	2.95E-01	5.15E-02	-2.236	CDK8,CMPK1,MAPK3,NME2,SGK1	
Oxytocin in Spinal Neurons Signaling Pathway	2.93E-01	5.71E-02	NaN	GNA11,NT5C	
Transcriptional Regulation by NPAS4	2.93E-01	5.71E-02	NaN	FOS,MAPK3	
Coagulation System	2.93E-01	5.71E-02	NaN	PLAT,PLAUR	
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	2.8E-01	6.67E-02	NaN	PTGES3	
Assembly of RNA Polymerase III Complex	2.8E-01	6.67E-02	NaN	GTF3C6	
Telomere Extension by Telomerase	2.8E-01	6.67E-02	NaN	HNRNPA2B1	
Striated Muscle Contraction	2.8E-01	5.56E-02	NaN	TMOD3,VIM	
MIF-mediated Glucocorticoid Regulation	2.8E-01	5.56E-02	NaN	MAPK3,NFKBIA	
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	2.68E-01	5.41E-02	NaN	CBX3,MBD3	
Granzyme B Signaling	2.62E-01	6.25E-02	NaN	CYCS	
Chondroitin Sulfate Degradation (Metazoa)	2.62E-01	6.25E-02	NaN	HYAL2	
Glutaryl-CoA Degradation	2.62E-01	6.25E-02	NaN	PARK7	
Bile Acid Biosynthesis, Neutral Pathway	2.62E-01	6.25E-02	NaN	SCP2	
Metabolism of water-soluble vitamins and cofactors	2.61E-01	5.08E-02	NaN	CD320,CYB5A,PDZD11	
Fanconi Anemia Pathway	2.56E-01	5.26E-02	NaN	RPS27A,UBC	
Visual phototransduction	2.52E-01	5E-02	NaN	FNTA,NMT1,TTR	
GADD45 Signaling	2.52E-01	5E-02	NaN	CDKN1A,GADD45B,GADD45G	
PI Metabolism	2.49E-01	4.88E-02	-2.000	ARF1,GDE1,PIP4P1,RAB5A	
Formation of Fibrin Clot (Clotting Cascade)	2.45E-01	5.13E-02	NaN	C1QBP,PROCR	
MAP kinase activation	2.45E-01	5.13E-02	NaN	RPS27A,UBC	
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	2.45E-01	5.88E-02	NaN	HRAS	
Transcriptional regulation of pluripotent stem cells	2.45E-01	5.88E-02	NaN	KLF4	
Isoleucine Degradation I	2.45E-01	5.88E-02	NaN	ECHS1	
Dermatan Sulfate Degradation (Metazoa)	2.45E-01	5.88E-02	NaN	HYAL2	
Assembly of collagen fibrils and other multimeric structures	2.44E-01	4.92E-02	NaN	CD151,COL14A1,CTSV	
NCAM signaling for neurite out-growth	2.44E-01	4.92E-02	NaN	HRAS,MAPK3,PRNP	
Neurotransmitter release cycle	2.35E-01	5E-02	NaN	ARL6IP5,SLC38A2	
Transcriptional Regulation by VENTX	2.35E-01	5E-02	NaN	ANAPC11,UBE2S	
Branched-chain amino acid catabolism	2.29E-01	5.56E-02	NaN	ECHS1	
Formation of definitive endoderm	2.29E-01	5.56E-02	NaN	SOX17	
Superpathway of Geranylgeranyldiphosphate Biosynthesis I (via Mevalonate)	2.29E-01	5.56E-02	NaN	FDPS	
RET signaling	2.25E-01	4.88E-02	NaN	DOK4,PDLIM7	
GABA synthesis, release, reuptake and degradation	2.15E-01	5.26E-02	NaN	HSPA8	
Î³-linolenate Biosynthesis II (Animals)	2.15E-01	5.26E-02	NaN	CYB5A	
Signaling by Hippo	2.01E-01	5E-02	NaN	YWHAE	
Class I peroxisomal membrane protein import	2.01E-01	5E-02	NaN	FIS1	
Valine Degradation I	2.01E-01	5E-02	NaN	ECHS1	
Neurovascular Coupling Signaling Pathway	-0E00	2.59E-02	-0.816	Calm1 (includes others),NT5C,PRDX6,PRKAR1A,RHOA,TBXA2R	
Pyroptosis Signaling Pathway	-0E00	4.26E-02	0.000	BAX,GAS5,PRKAR1A,RHOA	
CDX Gastrointestinal Cancer Signaling Pathway	-0E00	2.48E-02	-0.447	FOS,HBEGF,JUN,MAPK3,TNFSF12	
Macrophage Classical Activation Signaling Pathway	-0E00	3.7E-02	0.378	IFNGR1,NFKBIA,PDHB,PKM,SDHB,SDHD,TNFSF12	
Multiple Sclerosis Signaling Pathway	-0E00	4.5E-02	-2.530	BAX,DUSP1,GAS5,HLA-A,HLA-E,HLA-G,IFNGR1,MAPK3,PLP1,TNFSF12	
Pathogen Induced Cytokine Storm Signaling Pathway	-0E00	2.16E-02	-2.828	FOS,FTH1,FTL,IFNGR1,IRF7,JUN,MAPK3,TNFSF12	
Role of Chondrocytes in Rheumatoid Arthritis Signaling Pathway	-0E00	4.26E-02	-2.449	CEBPG,FOS,JUN,MAPK3,MMP15,PRKAB1	
Role of Osteoblasts in Rheumatoid Arthritis Signaling Pathway	-0E00	3.28E-02	-1.134	ACVRL1,ALPL,CSNK1E,CTSH,CTSV,MAPK3,MMP15,TNFSF12	
S100 Family Signaling Pathway	-0E00	3.5E-02	-4.811	ADRB2,ANXA2,ATF4,BSG,CACYBP,Calm1 (includes others),CDKN1A,COPS5,CREB3,FOS,GNA11,GPER1,HBEGF,IL10RB,ILK,JUN,MAPK3,MMP15,PDIA3,PLAT,PRKAR1A,RHOA,S100A10,S100A13,S100A16,S1PR1,TBXA2R	
Amyotrophic Lateral Sclerosis Signaling	-0E00	4.31E-02	-0.447	BAX,CYCS,GPX1,RAB5A,SSR4	
Fc Epsilon RI Signaling	-0E00	3.39E-02	NaN	HRAS,MAPK3,RASD1,RRAS	
IL-33 Signaling Pathway	-0E00	4.32E-02	-2.121	ATF4,CREB3,FOS,ICAM2,JUN,MAPK3,NFKBIA,PRKAR1A	
Activin Inhibin Signaling Pathway	-0E00	3.67E-02	-1.414	CDKN1A,FOS,JUN,MAPK3,NFKBIA,PMEPA1,RHOA,SOX17	
WNK Renal Signaling Pathway	-0E00	4.72E-02	NaN	ANAPC11,Calm1 (includes others),ELOC,LRRC8A,SGK1	
GABAergic Receptor Signaling Pathway (Enhanced)	-0E00	4.32E-02	-1.633	GNAI2,GNB2,GNG11,GNG5,PRKAR1A,SLC38A2	
Glutaminergic Receptor Signaling Pathway (Enhanced)	-0E00	4.62E-02	-3.873	ATF4,BAD,Calm1 (includes others),CREB3,EIF4E,GNAI2,GNAS,MAPK3,NAPA,PDIA3,PRDX6,PRKAR1A,SLC38A2,VAMP3,VTI1B	
NFKBIE Signaling Pathway	-0E00	4.45E-03	NaN	NFKBIA,TNFSF12	
LPS/IL-1 Mediated Inhibition of RXR Function	-0E00	3.11E-02	1.000	ALAS1,ALDH2,APOE,GSTM2,JUN,MGST3,NR1H2,PLTP	
G alpha (i) signalling events	-0E00	2.71E-02	-2.646	GNAI2,GNAS,GNB2,GNG11,GNG5,GNGT2,GPER1	
Fertilization	-0E00	3.85E-02	NaN	CD9	
Meiotic synapsis	-0E00	3.64E-02	NaN	LMNA,UBE2I	
Interleukin-7 signaling	-0E00	4.76E-02	NaN	SOCS2	
Potassium Channels	-0E00	3.88E-02	-2.000	GNB2,GNG11,GNG5,GNGT2	
Signaling by SCF-KIT	-0E00	4.65E-02	NaN	GRAP,HRAS	
Collagen degradation	-0E00	3.28E-02	NaN	COL14A1,MMP15	
Extracellular matrix organization	-0E00	4.72E-02	-2.236	CEACAM1,PDGFA,PDGFB,SPARC,TTR	
Glycerophospholipid biosynthesis	-0E00	1.01E-02	NaN	CSNK2B	
DAG and IP3 signaling	-0E00	2.44E-02	NaN	PRKAR1A	
Elastic fibre formation	-0E00	4.55E-02	NaN	FBLN2,LTBP4	
Telomere Maintenance	-0E00	1.37E-02	NaN	NOP10	
Mitochondrial biogenesis	-0E00	4.69E-02	NaN	ALAS1,CYCS,PRKAB1	
Glycosaminoglycan metabolism	-0E00	2.5E-02	NaN	B3GNT2,HYAL2	
MyD88:MAL(TIRAP) cascade initiated on plasma membrane	-0E00	4.76E-02	NaN	RPS27A,UBC	
Complement cascade	-0E00	7.41E-03	NaN	CD81	
Regulation of beta-cell development	-0E00	4.76E-02	NaN	HES1,SNW1	
Cellular hexose transport	-0E00	4.55E-02	NaN	SLC50A1	
Metabolism of porphyrins	-0E00	4.35E-02	NaN	ALAS1	
Cholesterol biosynthesis	-0E00	4E-02	NaN	FDPS	
Metabolism of steroid hormones	-0E00	2.86E-02	NaN	TSPO	
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	-0E00	3.47E-02	-2.646	CD34,CD81,HLA-A,HLA-E,HLA-G,ICAM2,NPDC1	
Signaling by BMP	-0E00	3.85E-02	NaN	ACVRL1	
Signaling by ALK	-0E00	3.57E-02	NaN	PTN	
Cell surface interactions at the vascular wall	-0E00	3.79E-02	-2.828	BSG,CAV1,CEACAM1,ESAM,F11R,HRAS,PPIA,PROCR	
Generic Transcription Pathway	-0E00	2.57E-02	-3.317	CDK8,MED10,MED7,MED8,NR1H2,NR2F6,NR4A1,NRBP1,SNW1,ZNF706,ZNF771	
Phase I - Functionalization of compounds	-0E00	1.96E-02	NaN	ADH5,ALDH2	
Integrin cell surface interactions	-0E00	3.53E-02	NaN	BSG,F11R,ICAM2	
DAP12 interactions	-0E00	4.76E-02	NaN	HLA-E,HRAS	
Activation of gene expression by SREBF (SREBP)	-0E00	2.44E-02	NaN	FDPS	
DNA Damage/Telomere Stress Induced Senescence	-0E00	1.79E-02	NaN	CDKN1A	
Syndecan interactions	-0E00	3.7E-02	NaN	TRAPPC4	
Class A/1 (Rhodopsin-like receptors)	-0E00	1.58E-02	-2.236	ADRB2,EDN1,GPER1,S1PR1,TBXA2R	
Peroxisomal lipid metabolism	-0E00	4.55E-02	NaN	SCP2	
G alpha (q) signalling events	-0E00	4.02E-02	-2.646	EDN1,GNA11,GNB2,GNG11,GNG5,GNGT2,TBXA2R	
Transport of bile salts and organic acids, metal ions and amine compounds	-0E00	1.2E-02	NaN	BSG	
Transport of inorganic cations/anions and amino acids/oligopeptides	-0E00	1.92E-02	NaN	SLC38A2,SRI	
NoRC negatively regulates rRNA expression	-0E00	2.63E-02	NaN	SAP18	
Other interleukin signaling	-0E00	4.17E-02	NaN	IL10RB	
Interleukin-3, Interleukin-5 and GM-CSF signaling	-0E00	3.64E-02	NaN	RPS27A,UBC	
O-linked glycosylation	-0E00	3.6E-02	-2.000	ADAMTS1,B3GNT2,POFUT2,ST6GALNAC4	
Miscellaneous transport and binding events	-0E00	3.85E-02	NaN	LRRC8A	
Signaling by Retinoic Acid	-0E00	2.27E-02	NaN	PDHB	
Cardiac conduction	-0E00	1.54E-02	NaN	ORAI1,SRI	
Surfactant metabolism	-0E00	4.35E-02	NaN	CTSH	
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	-0E00	4.46E-02	-2.236	RPS27A,SEM1,SUMO2,UBC,UBE2I	
Interleukin-10 signaling	-0E00	2.22E-02	NaN	IL10RB	
Keratinization	-0E00	4.67E-03	NaN	JUP	
Nucleosome assembly	-0E00	4.08E-02	NaN	NPM1,RUVBL1	
Interleukin-20 family signaling	-0E00	3.85E-02	NaN	IL10RB	
RUNX1 regulates megakaryocyte differentiation and platelet function	-0E00	3.45E-02	NaN	DPY30,PRMT1	
Collagen chain trimerization	-0E00	2.27E-02	NaN	COL14A1	
Cristae formation	-0E00	3.23E-02	NaN	MICOS13	
Transcriptional Regulation by E2F6	-0E00	2.94E-02	NaN	CBX3	
Nucleotide catabolism	-0E00	3.33E-02	NaN	NT5C	
Nucleotide salvage	-0E00	4.76E-02	NaN	GMPR2	
Transcriptional Regulation by MECP2	-0E00	1.59E-02	NaN	SGK1	
Signaling by NTRK2 (TRKB)	-0E00	4E-02	NaN	HRAS	
Signaling by Erythropoietin	-0E00	4E-02	NaN	HRAS	
Transcriptional regulation of granulopoiesis	-0E00	1.96E-02	NaN	CDKN1A	
EGR2 and SOX10-mediated initiation of Schwann cell myelination	-0E00	3.45E-02	NaN	PMP22	
Heme signaling	-0E00	2.13E-02	NaN	NFE2L2	
Retinoid metabolism and transport	-0E00	4.55E-02	NaN	APOE,TTR	
Formation of paraxial mesoderm	-0E00	4.35E-02	NaN	SNW1	
Formation of WDR5-containing histone-modifying complexes	-0E00	2.38E-02	NaN	DPY30	
Hepatic Cholestasis	-0E00	4.04E-02	-2.333	Calm1 (includes others),GPER1,JUN,MAPK3,NFKBIA,NR1H2,PRKAR1A,TNFRSF12A,TNFSF12	
LXR/RXR Activation	-0E00	4.07E-02	-2.000	APOE,ECHS1,NR1H2,PLTP,TTR	
Hepatic Fibrosis / Hepatic Stellate Cell Activation	-0E00	3.61E-02	NaN	BAX,EDN1,IFNGR1,KLF6,MYL6,PDGFA,PDGFB	
Autism Signaling Pathway	-0E00	4.55E-02	-2.673	ALDH2,EIF4E,EIF4EBP1,HLA-A,HLA-E,HLA-G,HRAS,MAPK3,PRKAR1A,RASD1,RHEB,RPS6,RRAS,TNFSF12	
BBSome Signaling Pathway	-0E00	3.27E-02	-3.000	ADRB2,BBIP1,CCT2,CCT3,CCT4,CCT5,CCT7,CCT8,GPER1,IFT20,PRKAR1A,RAB5A,RHOA,S1PR1,TBXA2R,XBP1	
HEY1 Signaling Pathway	-0E00	4.35E-02	-1.890	ACVRL1,BAX,CDKN1A,HEY1,MMP15,PRKAB1,PSENEN	
IL-27 Signaling Pathway	-0E00	4.69E-02	-2.449	GADD45G,HLA-A,HLA-E,HLA-G,IFNGR1,MCL1	
WNT/SHH Axonal Guidance Signaling Pathway	-0E00	4.03E-02	-1.633	ARF6,ILK,PRKAR1A,YWHAE,YWHAH,YWHAQ	
PXR/RXR Activation	-0E00	4.62E-02	NaN	ALAS1,GSTM2,PRKAR1A	
TR/RXR Activation	-0E00	1.56E-02	NaN	H3-3A/H3-3B,KLF9	
Role of BRCA1 in DNA Damage Response	-0E00	2.5E-02	NaN	ACTB,CDKN1A	
IL-12 Signaling and Production in Macrophages	-0E00	3.83E-02	1.000	APOE,Calm1 (includes others),FOS,H3-3A/H3-3B,IFNGR1,IL10RB,JUN,MAPK3,PRKAB1	
Role of RIG1-like Receptors in Antiviral Innate Immunity	-0E00	4.35E-02	NaN	IRF7,NFKBIA	
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	-0E00	1.92E-02	NaN	IRF7,MAPK3,TNFSF12	
TREM1 Signaling	-0E00	1.3E-02	NaN	MAPK3	
Role of NFAT in Regulation of the Immune Response	-0E00	1.64E-02	-3.317	Calm1 (includes others),CSNK1E,FOS,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HLA-A,HRAS,JUN,MAPK3,NFKBIA,ORAI1,RASD1,RRAS	
FcÎ³RIIB Signaling in B Lymphocytes	-0E00	5.65E-03	NaN	HRAS,RASD1,RRAS	
CCR5 Signaling in Macrophages	-0E00	1.8E-02	-2.236	Calm1 (includes others),FOS,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,JUN	
Calcium-induced T Lymphocyte Apoptosis	-0E00	8.7E-03	NaN	Calm1 (includes others),HLA-A,NR4A1,ORAI1	
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells	-0E00	9.41E-03	NaN	CYCS,HLA-A,HLA-E,HLA-G	
Airway Pathology in Chronic Obstructive Pulmonary Disease	-0E00	8.47E-03	NaN	TNFSF12	
CTLA4 Signaling in Cytotoxic T Lymphocytes	-0E00	3.45E-02	0.218	AP1S1,AP1S2,AP2A2,Ap2b1,AP2M1,AP2S1,ARF1,BCL10,CLTA,CLTB,FOS,H2-T22,HLA-A,HLA-E,HLA-G,HRAS,JUN,MAPK3,PPP2R2D,RASD1,RRAS	
Airway Inflammation in Asthma	-0E00	3.03E-02	NaN	IFNGR1	
T Helper Cell Differentiation	-0E00	6.37E-03	NaN	HLA-A,IFNGR1,IL10RB	
IL-9 Signaling	-0E00	2.86E-02	NaN	SOCS2	
CD28 Signaling in T Helper Cells	-0E00	2.51E-02	-3.317	ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,BCL10,Calm1 (includes others),FOS,HLA-A,JUN,NFKBIA	
IL-15 Signaling	-0E00	7.6E-03	-2.000	HRAS,MAPK3,RASD1,RRAS	
Dendritic Cell Maturation	-0E00	1.34E-02	-2.828	ATF4,CREB3,HLA-A,HLA-E,HLA-G,MAPK3,NFKBIA,PDIA3	
Neuropathic Pain Signaling in Dorsal Horn Neurons	-0E00	3.96E-02	-2.000	FOS,MAPK3,PDIA3,PRKAR1A	
Factors Promoting Cardiogenesis in Vertebrates	-0E00	3.27E-02	-2.000	ACVRL1,ATF4,CREB3,PDIA3,RHOA	
Cardiomyocyte Differentiation via BMP Receptors	-0E00	3.7E-02	NaN	ACVRL1	
ICOS-ICOSL Signaling in T Helper Cells	-0E00	7.89E-03	NaN	BAD,Calm1 (includes others),HLA-A,NFKBIA	
Molecular Mechanisms of Cancer	-0E00	4.44E-02	-4.542	ACVRL1,ADRB2,BAD,BAX,BBC3,Cdc42,CDKN1A,CYCS,EDN1,FOS,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,GPER1,HES1,HEY1,HRAS,ID1,IL10RB,JUN,LAMTOR3,MAPK3,MMP15,NFKBIA,PDGFB,PRKAR1A,PSENEN,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,S1PR1,TBXA2R	
Lipid Antigen Presentation by CD1	-0E00	1.45E-02	NaN	AP2A2,Ap2b1,AP2M1,AP2S1,ARF6,PDIA3	
Maturity Onset Diabetes of Young (MODY) Signaling	-0E00	2.53E-02	NaN	APOE,GAPDH	
Role of CHK Proteins in Cell Cycle Checkpoint Control	-0E00	3.45E-02	NaN	CDKN1A,PPP2R2D	
Role of OCT4 in Mammalian Embryonic Stem Cell Pluripotency	-0E00	4.35E-02	NaN	NR2F6,SH3GLB1	
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency	-0E00	4.03E-02	NaN	ACVRL1,HRAS,MAPK3,RASD1,RRAS	
Growth Hormone Signaling	-0E00	4.23E-02	NaN	FOS,MAPK3,SOCS2	
CREB Signaling in Neurons	-0E00	4.61E-02	-3.500	ADRB2,ATF4,Calm1 (includes others),CREB3,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,GPER1,GTF2B,HRAS,MAPK3,PDGFB,PDIA3,POLR2C,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,PRKAR1A,RASD1,RRAS,S1PR1,TBXA2R	
Type I Diabetes Mellitus Signaling	-0E00	1.57E-02	-1.000	CYCS,HLA-A,HLA-E,HLA-G,HSPD1,IFNGR1,NFKBIA,SOCS2	
Small Cell Lung Cancer Signaling	-0E00	3.12E-02	NaN	CYCS,NFKBIA,TRAF5	
Primary Immunodeficiency Signaling	-0E00	1.64E-02	NaN	TAP2	
Allograft Rejection Signaling	-0E00	8.2E-03	NaN	H2-T22,HLA-A,HLA-E,HLA-G	
Autoimmune Thyroid Disease Signaling	-0E00	6.54E-03	NaN	HLA-A,HLA-E,HLA-G	
Graft-versus-Host Disease Signaling	-0E00	6.73E-03	NaN	HLA-A,HLA-E,HLA-G	
Type II Diabetes Mellitus Signaling	-0E00	3.92E-02	-1.000	MAPK3,NFKBIA,PKM,PRKAB1,SMPD2,SOCS2	
p70S6K Signaling	-0E00	2.25E-02	-2.121	BAD,BCAP31,GNAI2,HRAS,MAPK3,PDIA3,PPP2R2D,RASD1,RPS6,RRAS,YWHAE,YWHAH,YWHAQ	
Pancreatic Adenocarcinoma Signaling	-0E00	3.17E-02	-1.000	BAD,CDKN1A,HBEGF,MAPK3	
G Protein Signaling Mediated by Tubby	-0E00	1.28E-02	-2.449	GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5	
Communication between Innate and Adaptive Immune Cells	-0E00	3.22E-03	NaN	HLA-A,HLA-E,HLA-G	
Systemic Lupus Erythematosus Signaling	-0E00	2.72E-02	NaN	CREM,FOS,HLA-A,HLA-E,HLA-G,HNRNPA2B1,HRAS,JUN,LSM10,LSM12,LSM2,LSM3,LSM5,MAPK3,RASD1,RRAS,SF3B4,SNRNP27,SNRPB,Snrpc,SNRPD1,SNRPD3,Snrpe,SNRPF,Snrpg,SNU13,TXNL4A,ZCRB1,ZMAT5	
CDC42 Signaling	-0E00	3.3E-02	-3.873	ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,CDC42EP2,CFL1,CFL2,FOS,H2-T22,HLA-A,HLA-E,HLA-G,JUN,MYL12A,MYL12B,MYL6	
FAK Signaling	-0E00	2.31E-02	-3.266	ADRB2,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,BAD,CDH5,FOS,GPER1,HRAS,IL10RB,JUN,MAPK3,RASD1,RHOA,RRAS,S1PR1,SDCBP,SH3GL1,SOCS2,TBXA2R	
Retinoic acid Mediated Apoptosis Signaling	-0E00	1.67E-02	NaN	CYCS	
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis	-0E00	4.39E-02	NaN	ACVRL1,ALPL,BAD,Calm1 (includes others),CSNK1E,FOS,JUN,MAPK3,NFKBIA,TRAF5	
Phospholipase C Signaling	-0E00	1.79E-02	-3.873	ATF4,Calm1 (includes others),Cdc42,CREB3,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,MYL12A,MYL12B,MYL6,PEBP1,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
Ovarian Cancer Signaling	-0E00	3.8E-02	-2.236	EDN1,HRAS,MAPK3,PRKAR1A,RASD1,RRAS	
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis	-0E00	1.07E-03	NaN	HLA-A	
Atherosclerosis Signaling	-0E00	4.51E-02	NaN	APOE,PDGFA,PDGFB,PRDX6,TNFRSF12A,TNFSF12	
Leptin Signaling in Obesity	-0E00	3.95E-02	NaN	MAPK3,PDIA3,PRKAR1A	
B Cell Development	-0E00	2.05E-03	NaN	HLA-A	
Breast Cancer Regulation by Stathmin1	-0E00	4.71E-02	-2.117	ADRB2,ATF4,CREB3,GNB2,GNG11,GNG5,GPER1,HRAS,JUN,MAPK3,PDGFB,PPP1CA,PPP1R11,PPP1R14B,PRKAR1A,RASD1,RHOA,RRAS,S1PR1,STMN1,TBXA2R,TUBA1A,TUBA1B,TUBA1C,TUBB,TUBB2A,TUBB2B,TUBB4B	
Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes	-0E00	2.16E-02	-3.162	BCL10,Calm1 (includes others),FOS,HRAS,JUN,MAPK3,NFKBIA,PABPC4,RASD1,RRAS	
Role of WNT/GSK-3Î² Signaling in the Pathogenesis of Influenza	-0E00	1.28E-02	NaN	CSNK1E	
NUR77 Signaling in T Lymphocytes	-0E00	1.56E-02	-2.000	Calm1 (includes others),CYCS,H2-T22,HLA-A,HLA-E,HLA-G,MAPK3,NR4A1	
PKCÎ¸ Signaling in T Lymphocytes	-0E00	1.61E-02	-2.828	BCL10,FOS,HLA-A,HRAS,JUN,MAPK3,NFKBIA,RASD1,RRAS	
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza	-0E00	4.55E-02	NaN	GNAI2,MAPK3,NFKBIA	
Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza	-0E00	4.65E-02	-1.000	IRF7,ISG15,RSAD2,S1PR1	
Antiproliferative Role of TOB in T Cell Signaling	-0E00	2.35E-03	NaN	PABPC4	
MSP-RON Signaling Pathway	-0E00	3.45E-02	NaN	ACTB,ACTG1	
OX40 Signaling Pathway	-0E00	1.46E-02	NaN	H2-T22,HLA-A,HLA-E,HLA-G,JUN,NFKBIA,TRAF5	
PI3K Signaling in B Lymphocytes	-0E00	2.21E-02	-3.317	ATF3,ATF4,BCL10,Calm1 (includes others),CD81,FOS,HRAS,JUN,MAPK3,NFKBIA,PDIA3,RASD1,RRAS	
Inhibition of Angiogenesis by TSP1	-0E00	2.94E-02	NaN	JUN	
Cyclins and Cell Cycle Regulation	-0E00	2.33E-02	NaN	CDKN1A,PPP2R2D	
Cell Cycle Control of Chromosomal Replication	-0E00	3.57E-02	NaN	CDK8,CDK9	
IL-17A Signaling in Airway Cells	-0E00	2.99E-02	NaN	MAPK3,NFKBIA	
Role of IL-17A in Arthritis	-0E00	3.51E-02	NaN	MAPK3,NFKBIA	
Role of JAK1, JAK2 and TYK2 in Interferon Signaling	-0E00	3.85E-02	NaN	IFNGR1	
Role of JAK2 in Hormone-like Cytokine Signaling	-0E00	3.23E-02	NaN	FOS,SOCS2	
Transcriptional Regulatory Network in Embryonic Stem Cells	-0E00	3.05E-02	-2.236	HRAS,KLF4,MAPK3,RASD1,RRAS	
nNOS Signaling in Neurons	-0E00	4.26E-02	NaN	Calm1 (includes others),RASD1	
nNOS Signaling in Skeletal Muscle Cells	-0E00	2.08E-02	NaN	Calm1 (includes others)	
Estrogen-mediated S-phase Entry	-0E00	3.85E-02	NaN	CDKN1A	
Heparan Sulfate Biosynthesis	-0E00	2.22E-02	NaN	ALDH2,PRDX6	
Dopamine Degradation	-0E00	3.12E-02	NaN	ALDH2	
Heparan Sulfate Biosynthesis (Late Stages)	-0E00	2.41E-02	NaN	ALDH2,PRDX6	
The Visual Cycle	-0E00	4.17E-02	NaN	DHRS7	
NAD Salvage Pathway II	-0E00	3.7E-02	NaN	NT5C	
Pyridoxal 5'-phosphate Salvage Pathway	-0E00	4.62E-02	NaN	CDK8,MAPK3,SGK1	
Triacylglycerol Degradation	-0E00	3.45E-02	NaN	ALDH2,PRDX6	
Phospholipases	-0E00	2.9E-02	NaN	PDIA3,PRDX6	
tRNA Charging	-0E00	2.56E-02	NaN	GARS1	
Phosphatidylglycerol Biosynthesis II (Non-plastidic)	-0E00	3.33E-02	NaN	PTPMT1	
Serotonin Degradation	-0E00	4.11E-02	NaN	ADH5,AKR1A1,ALDH2	
Retinol Biosynthesis	-0E00	4.17E-02	NaN	DHRS7,ESD	
Tryptophan Degradation III (Eukaryotic)	-0E00	4.35E-02	NaN	PARK7	
Triacylglycerol Biosynthesis	-0E00	1.79E-02	NaN	Plpp1	
Histamine Degradation	-0E00	4.76E-02	NaN	ALDH2	
Stearate Biosynthesis I (Animals)	-0E00	4.23E-02	NaN	ACOT9,DHRS7,PPT1	
Acetone Degradation I (to Methylglyoxal)	-0E00	2.38E-02	NaN	DHRS7	
Fatty Acid Î±-oxidation	-0E00	4.76E-02	NaN	ALDH2	
Oxidative Ethanol Degradation III	-0E00	1.79E-02	NaN	ALDH2	
Ethanol Degradation IV	-0E00	4E-02	NaN	ALDH2	
Superpathway of Cholesterol Biosynthesis	-0E00	3.45E-02	NaN	FDPS	
Antioxidant Action of Vitamin C	-0E00	4.39E-02	NaN	MAPK3,NFKBIA,PDIA3,PRDX6,TXN	
DNA damage-induced 14-3-3Ï Signaling	-0E00	4.35E-02	NaN	BAD,CDKN1A	
Inhibition of Matrix Metalloproteases	-0E00	2.56E-02	NaN	MMP15	
Regulation of Cellular Mechanics by Calpain Protease	-0E00	4.44E-02	NaN	HRAS,MAPK3,RASD1,RRAS	
Agranulocyte Adhesion and Diapedesis	-0E00	4.76E-02	NaN	ACTB,ACTG1,CD34,CDH5,CLDN5,GNAI2,ICAM2,MMP15,MYL6,RDX	
Granulocyte Adhesion and Diapedesis	-0E00	3.17E-02	NaN	CDH5,CLDN5,GNAI2,ICAM2,MMP15,RDX	
Regulation of the Epithelial-Mesenchymal Transition Pathway	-0E00	3.59E-02	NaN	HRAS,ID2,MAPK3,PSENEN,RASD1,RHOA,RRAS	
Role of p14/p19ARF in Tumor Suppression	-0E00	3.33E-02	NaN	NPM1	
Sperm Motility	-0E00	3.89E-02	-2.000	Calm1 (includes others),GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,PDIA3,PRDX6,PRKAR1A	
TEC Kinase Signaling	-0E00	2.6E-02	-2.828	ACTB,ACTG1,Cdc42,FOS,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,RHOA,RHOB,RHOC,RHOG,TNFSF12	
Adipogenesis pathway	-0E00	2.88E-02	0.000	ACVRL1,DDIT3,SAP18,XBP1	
BER (Base Excision Repair) Pathway	-0E00	4.55E-02	NaN	ARL6IP5,MAPK3	
WNT/Ca+ pathway	-0E00	4.55E-02	NaN	ATF4,CREB3,PDIA3	
SAPK/JNK Signaling	-0E00	1.79E-02	-1.890	DUSP8,GNB2,GNG11,GNG5,HNRNPK,HRAS,JUN,RASD1,RRAS	
FGF Signaling	-0E00	4.65E-02	-2.000	ATF4,CREB3,HRAS,MAPK3	
IL-4 Signaling	-0E00	1.39E-02	-2.121	ATF4,CREB3,EIF4EBP1,GNAI2,HRAS,MAPK3,RASD1,RRAS	
B Cell Receptor Signaling	-0E00	2.05E-02	-2.887	ATF4,BAD,BCL10,Calm1 (includes others),CFL1,CFL2,CREB3,HRAS,JUN,MAPK3,NFKBIA,RASD1,RRAS	
Phototransduction Pathway	-0E00	3.7E-02	NaN	GNGT2,PRKAR1A	
Sonic Hedgehog Signaling	-0E00	3.23E-02	NaN	PRKAR1A	
NF-ÎºB Signaling	-0E00	1.23E-02	-1.633	BCL10,CSNK2B,HRAS,NFKBIA,RASD1,RRAS,TRAF5	
T Cell Receptor Signaling	-0E00	2.11E-02	-2.887	BCL10,Calm1 (includes others),FOS,H2-T22,HLA-A,HLA-E,HLA-G,HRAS,JUN,MAPK3,NFKBIA,RASD1,RRAS	
G-Protein Coupled Receptor Signaling	-0E00	3.84E-02	-4.041	ADRB2,ATF4,Calm1 (includes others),CREB3,DUSP1,FOS,GDE1,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,GPER1,HRAS,JUN,MAPK3,MYL12A,MYL12B,MYL6,NFKBIA,PRKAR1A,RASD1,RRAS,S1PR1,SMPDL3A,TBXA2R	
Gustation Pathway	-0E00	1.49E-02	NaN	LRRC8A,ORAI1,PRKAR1A	
Phagosome Formation	-0E00	3.74E-02	-4.315	ADRB2,AP1S1,AP1S2,ARF6,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPC5L,BCL10,CFL1,CFL2,GPER1,HRAS,MAPK3,MYL12A,MYL12B,MYL6,PRDX6,RASD1,RHOA,RRAS,S1PR1,TBXA2R	
PD-1, PD-L1 cancer immunotherapy pathway	-0E00	4.67E-02	1.342	CSNK2B,HLA-A,HLA-E,HLA-G,IFNGR1	
Th1 and Th2 Activation Pathway	-0E00	3.49E-02	NaN	HLA-A,IFNGR1,IL10RB,JUN,PSENEN,S1PR1	
Th1 Pathway	-0E00	3.28E-02	-2.000	HLA-A,IFNGR1,IL10RB,PSENEN	
Th2 Pathway	-0E00	2.92E-02	-1.000	HLA-A,JUN,PSENEN,S1PR1	
Osteoarthritis Pathway	-0E00	3.81E-02	-0.378	ACVRL1,ALPL,ANXA2,ANXA5,ATF4,CREB3,HES1,HTRA1,PRKAB1	
GP6 Signaling Pathway	-0E00	1.57E-02	NaN	Calm1 (includes others),RHOG	
Neuroinflammation Signaling Pathway	-0E00	3.79E-02	-3.162	ATF4,CREB3,FOS,HLA-A,HLA-E,HLA-G,IFNGR1,IRF7,JUN,MAPK3,NFE2L2,PSENEN	
Th17 Activation Pathway	-0E00	6.2E-03	NaN	HSP90AA1,HSP90AB1,HSP90B1	
Apelin Liver Signaling Pathway	-0E00	3.7E-02	NaN	EDN1	
Apelin Cardiac Fibroblast Signaling Pathway	-0E00	4.35E-02	NaN	PRKAB1	
Cardiac Hypertrophy Signaling (Enhanced)	-0E00	4.8E-02	-4.379	ADRB2,Calm1 (includes others),EDN1,EIF2B4,EIF4E,EIF4EBP1,GDE1,GNA11,GNAI2,GNAS,GNB2,GNG11,GNG5,HRAS,HSPB1,IL10RB,JUN,MAPK3,PDIA3,PRKAR1A,RASD1,RHOA,RPS6,RRAS,SMPDL3A,TNFSF12	
FAT10 Cancer Signaling Pathway	-0E00	4E-02	NaN	EEF1A1,NFKBIA	
T Cell Exhaustion Signaling Pathway	-0E00	1.94E-02	NaN	FOS,HLA-A,HLA-E,HLA-G,HRAS,IL10RB,JUN,MAPK3,PPP2R2D,RASD1,RRAS	
IL-23 Signaling Pathway	-0E00	2.17E-02	NaN	NFKBIA	
Systemic Lupus Erythematosus in T Cell Signaling Pathway	-0E00	3.42E-02	-1.091	ATF4,Cdc42,CREB3,CREM,FOS,GNAI2,H2-T22,HLA-A,HLA-E,HLA-G,HRAS,JUN,MAPK3,ORAI1,PPP2R2D,RASD1,RDX,RHOA,RHOB,RHOC,RHOG,RRAS	
Systemic Lupus Erythematosus in B Cell Signaling Pathway	-0E00	2.07E-02	-3.357	BAD,BCL10,Calm1 (includes others),FOS,HRAS,IFNGR1,IRF7,ISG15,JUN,MAPK3,MCL1,RASD1,RRAS,TNFSF12,TRAF5	
White Adipose Tissue Browning Pathway	-0E00	4.35E-02	-2.449	ATF4,CREB3,GNAS,LDHA,PRKAB1,PRKAR1A	
HOTAIR Regulatory Pathway	-0E00	3.68E-02	-0.447	CDKN1A,H3-3A/H3-3B,MMP15,NFKBIA,RHOC,VIM	
Regulation of the Epithelial Mesenchymal Transition in Development Pathway	-0E00	1.15E-02	NaN	PSENEN	
Calcium Signaling	-0E00	2.73E-02	-2.236	ATF4,Calm1 (includes others),CREB3,MAPK3,MYL6,PRKAR1A	
Complement System	-0E00	2.7E-02	NaN	C1QBP	
